QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State of Incorporation) | (I.R.S. Employer Identification No.) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
☒ | Accelerated filer | ☐ | ||||||||||||||||||
Non-accelerated filer | ☐ | Smaller reporting company | ||||||||||||||||||
Emerging growth company |
Page | |||||
Item 1: Financial Statements (Unaudited) | |||||
Item 4: Controls and Procedures | |||||
Item 1: Legal Proceedings | |||||
Item 1A: Risk Factors | |||||
Item 5: Other Information | |||||
Item 6: Exhibits | |||||
Three Months Ended March 31, | |||||||||||
In thousands, except per share data | 2023 | 2022 | |||||||||
Revenues | |||||||||||
Product revenues | $ | $ | |||||||||
Service revenues | |||||||||||
Total revenues | |||||||||||
Cost of revenues | |||||||||||
Product cost of revenues | |||||||||||
Service cost of revenues | |||||||||||
Total cost of revenues | |||||||||||
Gross profit | |||||||||||
Operating expenses | |||||||||||
Sales, general and administrative | |||||||||||
Research and development | |||||||||||
Amortization of intangible assets | |||||||||||
Restructuring | ( | ||||||||||
Loss on sale of business | |||||||||||
Total operating expenses | |||||||||||
Operating income (loss) | ( | ||||||||||
Other income (expense) | |||||||||||
Interest income | |||||||||||
Interest expense | ( | ( | |||||||||
Other income (expense), net | ( | ( | |||||||||
Total other income (expense) | ( | ( | |||||||||
Income (loss) before income taxes | ( | ||||||||||
Income tax benefit (provision) | ( | ||||||||||
Net income (loss) | ( | ||||||||||
Net loss attributable to noncontrolling interests | ( | ( | |||||||||
Net income (loss) attributable to Itron, Inc. | $ | ( | $ | ||||||||
Net income (loss) per common share - Basic | $ | ( | $ | ||||||||
Net income (loss) per common share - Diluted | $ | ( | $ | ||||||||
Weighted average common shares outstanding - Basic | |||||||||||
Weighted average common shares outstanding - Diluted |
Three Months Ended March 31, | |||||||||||
In thousands | 2023 | 2022 | |||||||||
Net income (loss) | $ | ( | $ | ||||||||
Other comprehensive income (loss), net of tax: | |||||||||||
Foreign currency translation adjustments | ( | ||||||||||
Foreign currency translation adjustment reclassified to net income (loss) on sale of business | |||||||||||
Pension benefit obligation adjustment | ( | ||||||||||
Total other comprehensive income (loss), net of tax | |||||||||||
Total comprehensive income (loss), net of tax | ( | ||||||||||
Comprehensive loss attributable to noncontrolling interests, net of tax | ( | ( | |||||||||
Comprehensive income (loss) attributable to Itron, Inc. | $ | ( | $ |
In thousands | March 31, 2023 | December 31, 2022 | |||||||||
ASSETS | |||||||||||
Current assets | |||||||||||
Cash and cash equivalents | $ | $ | |||||||||
Accounts receivable, net | |||||||||||
Inventories | |||||||||||
Other current assets | |||||||||||
Total current assets | |||||||||||
Property, plant, and equipment, net | |||||||||||
Deferred tax assets, net | |||||||||||
Other long-term assets | |||||||||||
Operating lease right-of-use assets, net | |||||||||||
Intangible assets, net | |||||||||||
Goodwill | |||||||||||
Total assets | $ | $ | |||||||||
LIABILITIES AND EQUITY | |||||||||||
Current liabilities | |||||||||||
Accounts payable | $ | $ | |||||||||
Other current liabilities | |||||||||||
Wages and benefits payable | |||||||||||
Taxes payable | |||||||||||
Current portion of warranty | |||||||||||
Unearned revenue | |||||||||||
Total current liabilities | |||||||||||
Long-term debt, net | |||||||||||
Long-term warranty | |||||||||||
Pension benefit obligation | |||||||||||
Deferred tax liabilities, net | |||||||||||
Operating lease liabilities | |||||||||||
Other long-term obligations | |||||||||||
Total liabilities | |||||||||||
Equity | |||||||||||
Preferred stock, no par value, | |||||||||||
Common stock, no par value, | |||||||||||
Accumulated other comprehensive loss, net | ( | ( | |||||||||
Accumulated deficit | ( | ( | |||||||||
Total Itron, Inc. shareholders' equity | |||||||||||
Noncontrolling interests | |||||||||||
Total equity | |||||||||||
Total liabilities and equity | $ | $ |
Common Stock | Accumulated Other Comprehensive Loss | Accumulated Deficit | Total Itron, Inc. Shareholders' Equity | Noncontrolling Interests | Total Equity | ||||||||||||||||||||||||||||||||||||
In thousands | Shares | Amount | |||||||||||||||||||||||||||||||||||||||
Balances at January 1, 2023 | $ | $ | ( | $ | ( | $ | $ | $ | |||||||||||||||||||||||||||||||||
Net income (loss) | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||
Other comprehensive income (loss), net of tax | |||||||||||||||||||||||||||||||||||||||||
Distributions to noncontrolling interests | ( | ( | |||||||||||||||||||||||||||||||||||||||
Net stock issued and repurchased | |||||||||||||||||||||||||||||||||||||||||
Stock-based compensation expense | |||||||||||||||||||||||||||||||||||||||||
Balances at March 31, 2023 | $ | $ | ( | $ | ( | $ | $ | $ | |||||||||||||||||||||||||||||||||
Common Stock | Accumulated Other Comprehensive Loss | Accumulated Deficit | Total Itron, Inc. Shareholders' Equity | Noncontrolling Interests | Total Equity | ||||||||||||||||||||||||||||||||||||
In thousands | Shares | Amount | |||||||||||||||||||||||||||||||||||||||
Balances at January 1, 2022 | $ | $ | ( | $ | ( | $ | $ | $ | |||||||||||||||||||||||||||||||||
Net income (loss) | ( | ||||||||||||||||||||||||||||||||||||||||
Other comprehensive income (loss), net of tax | |||||||||||||||||||||||||||||||||||||||||
Net stock issued and repurchased | |||||||||||||||||||||||||||||||||||||||||
Stock-based compensation expense | |||||||||||||||||||||||||||||||||||||||||
Stock repurchased program | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||
Balances at March 31, 2022 | $ | $ | ( | $ | ( | $ | $ | $ | |||||||||||||||||||||||||||||||||
Three Months Ended March 31, | |||||||||||
In thousands | 2023 | 2022 | |||||||||
Operating activities | |||||||||||
Net income (loss) | $ | ( | $ | ||||||||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||||||||
Depreciation and amortization of intangible assets | |||||||||||
Non-cash operating lease expense | |||||||||||
Stock-based compensation | |||||||||||
Amortization of prepaid debt fees | |||||||||||
Deferred taxes, net | ( | ( | |||||||||
Loss on sale of business | |||||||||||
Restructuring, non-cash | |||||||||||
Other adjustments, net | |||||||||||
Changes in operating assets and liabilities, net of acquisition and sale of business: | |||||||||||
Accounts receivable | ( | ( | |||||||||
Inventories | ( | ( | |||||||||
Other current assets | ( | ( | |||||||||
Other long-term assets | ( | ||||||||||
Accounts payable, other current liabilities, and taxes payable | |||||||||||
Wages and benefits payable | ( | ( | |||||||||
Unearned revenue | |||||||||||
Warranty | ( | ( | |||||||||
Restructuring | ( | ||||||||||
Other operating, net | ( | ( | |||||||||
Net cash provided by operating activities | |||||||||||
Investing activities | |||||||||||
Net proceeds (payments) related to the sale of business | ( | ||||||||||
Acquisitions of property, plant, and equipment | ( | ( | |||||||||
Business acquisitions, net of cash and cash equivalents acquired | |||||||||||
Other investing, net | |||||||||||
Net cash provided by (used in) investing activities | ( | ||||||||||
Financing activities | |||||||||||
Issuance of common stock | |||||||||||
Repurchase of common stock | ( | ||||||||||
Prepaid debt fees | ( | ( | |||||||||
Other financing, net | ( | ( | |||||||||
Net cash used in financing activities | ( | ( | |||||||||
Effect of foreign exchange rate changes on cash and cash equivalents | ( | ||||||||||
Increase (decrease) in cash and cash equivalents | ( | ||||||||||
Cash and cash equivalents at beginning of period | |||||||||||
Cash and cash equivalents at end of period | $ | $ | |||||||||
Supplemental disclosure of cash flow information: | |||||||||||
Cash paid during the period for: | |||||||||||
Income taxes, net | $ | $ | |||||||||
Interest |
Three Months Ended March 31, 2022 | |||||||||||||||||
In thousands | As Previously Reported | Adjustments | As Reclassified | ||||||||||||||
Changes in operating assets and liabilities, net of acquisitions and sale of business: | |||||||||||||||||
Accounts payable, other current liabilities, and taxes payable | $ | $ | $ | ||||||||||||||
Restructuring | ( | ( | |||||||||||||||
Other operating, net | ( | ( |
Three Months Ended March 31, | |||||||||||
In thousands, except per share data | 2023 | 2022 | |||||||||
Net income (loss) available to common shareholders | $ | ( | $ | ||||||||
Weighted average common shares outstanding - Basic | |||||||||||
Dilutive effect of stock-based awards | |||||||||||
Dilutive effect of convertible notes | |||||||||||
Weighted average common shares outstanding - Diluted | |||||||||||
Net income (loss) per common share - Basic | $ | ( | $ | ||||||||
Net income (loss) per common share - Diluted | $ | ( | $ |
Accounts receivable, net | |||||||||||
In thousands | March 31, 2023 | December 31, 2022 | |||||||||
Trade receivables (net of allowance of $ | $ | $ | |||||||||
Unbilled receivables | |||||||||||
Total accounts receivable, net | $ | $ |
Allowance for credit losses account activity | Three Months Ended March 31, | ||||||||||
In thousands | 2023 | 2022 | |||||||||
Beginning balance | $ | $ | |||||||||
Provision for (release of) doubtful accounts, net | ( | ( | |||||||||
Accounts recovered (written-off), net | ( | ||||||||||
Effect of change in exchange rates | ( | ||||||||||
Ending balance | $ | $ |
Inventories | |||||||||||
In thousands | March 31, 2023 | December 31, 2022 | |||||||||
Raw materials | $ | $ | |||||||||
Work in process | |||||||||||
Finished goods | |||||||||||
Total inventories | $ | $ |
Property, plant, and equipment, net | |||||||||||
In thousands | March 31, 2023 | December 31, 2022 | |||||||||
Machinery and equipment | $ | $ | |||||||||
Computers and software | |||||||||||
Buildings, furniture, and improvements | |||||||||||
Land | |||||||||||
Construction in progress, including purchased equipment | |||||||||||
Total cost | |||||||||||
Accumulated depreciation | ( | ( | |||||||||
Property, plant, and equipment, net | $ | $ |
Depreciation expense | Three Months Ended March 31, | ||||||||||
In thousands | 2023 | 2022 | |||||||||
Depreciation expense | $ | $ |
March 31, 2023 | December 31, 2022 | ||||||||||||||||||||||||||||||||||
In thousands | Gross | Accumulated (Amortization) Accretion | Net | Gross | Accumulated (Amortization) Accretion | Net | |||||||||||||||||||||||||||||
Intangible Assets | |||||||||||||||||||||||||||||||||||
Core-developed technology | $ | $ | ( | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||
Customer contracts and relationships | ( | ( | |||||||||||||||||||||||||||||||||
Trademarks and trade names | ( | ( | |||||||||||||||||||||||||||||||||
Other | ( | ( | |||||||||||||||||||||||||||||||||
Total intangible assets | $ | $ | ( | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||
Intangible Liabilities | |||||||||||||||||||||||||||||||||||
Customer contracts and relationships | $ | ( | $ | $ | $ | ( | $ | $ |
Three Months Ended March 31, | |||||||||||
In thousands | 2023 | 2022 | |||||||||
Intangible assets, gross beginning balance | $ | $ | |||||||||
Effect of change in exchange rates | ( | ||||||||||
Intangible assets, gross ending balance | $ | $ | |||||||||
Intangible liabilities, gross beginning balance | $ | ( | $ | ( | |||||||
Effect of change in exchange rates | |||||||||||
Intangible liabilities, gross ending balance | $ | ( | $ | ( |
Year Ending December 31, | Estimated Annual Amortization | |||||||
In thousands | ||||||||
2023 (amount remaining at March 31, 2023) | $ | |||||||
2024 | ||||||||
2025 | ||||||||
2026 | ||||||||
2027 | ||||||||
Thereafter | ||||||||
Total intangible assets subject to amortization | $ |
In thousands | Device Solutions | Networked Solutions | Outcomes | Total Company | |||||||||||||||||||
Goodwill balance at January 1, 2023 | $ | $ | $ | $ | |||||||||||||||||||
Effect of change in exchange rates | |||||||||||||||||||||||
Goodwill balance at March 31, 2023 | $ | $ | $ | $ |
In thousands | March 31, 2023 | December 31, 2022 | |||||||||
Credit facility | |||||||||||
Multicurrency revolving line of credit | $ | $ | |||||||||
Convertible notes | |||||||||||
Total debt | |||||||||||
Less: unamortized prepaid debt fees - convertible notes | |||||||||||
Long-term debt, net | $ | $ |
Year Ending December 31, | Minimum Payments | ||||
In thousands | |||||
2023 (amount remaining at March 31, 2023) | $ | ||||
2024 | |||||
2025 | |||||
2026 | |||||
2027 | |||||
Thereafter | |||||
Total minimum payments on debt | $ |
In thousands | March 31, 2023 | December 31, 2022 | |||||||||
Assets | |||||||||||
Plan assets in other long-term assets | $ | $ | |||||||||
Liabilities | |||||||||||
Current portion of pension benefit obligation in wages and benefits payable | $ | $ | |||||||||
Long-term portion of pension benefit obligation | |||||||||||
Pension benefit obligation, net | $ | $ |
Three Months Ended March 31, | |||||||||||
In thousands | 2023 | 2022 | |||||||||
Service cost | $ | $ | |||||||||
Interest cost | |||||||||||
Expected return on plan assets | ( | ( | |||||||||
Amortization of prior service costs | |||||||||||
Amortization of actuarial net loss | ( | ||||||||||
Net periodic benefit cost | $ | $ |
Three Months Ended March 31, | |||||||||||
In thousands | 2023 | 2022 | |||||||||
Stock options | $ | $ | |||||||||
Restricted stock units | |||||||||||
Unrestricted stock awards | |||||||||||
Phantom stock units | |||||||||||
Total stock-based compensation | $ | $ | |||||||||
Related tax benefit | $ | $ |
Shares | Weighted Average Exercise Price per Share | Weighted Average Remaining Contractual Life | Aggregate Intrinsic Value | Weighted Average Grant Date Fair Value | |||||||||||||||||||||||||
In thousands | Years | In thousands | |||||||||||||||||||||||||||
Outstanding, January 1, 2022 | $ | $ | |||||||||||||||||||||||||||
Granted | $ | ||||||||||||||||||||||||||||
Exercised | |||||||||||||||||||||||||||||
Forfeited | ( | ||||||||||||||||||||||||||||
Outstanding, March 31, 2022 | $ | $ | |||||||||||||||||||||||||||
Outstanding, January 1, 2023 | $ | $ | |||||||||||||||||||||||||||
Granted | $ | ||||||||||||||||||||||||||||
Exercised | |||||||||||||||||||||||||||||
Forfeited | |||||||||||||||||||||||||||||
Canceled | |||||||||||||||||||||||||||||
Outstanding, March 31, 2023 | $ | $ | |||||||||||||||||||||||||||
Exercisable, March 31, 2023 | $ | $ | |||||||||||||||||||||||||||
In thousands, except fair value | Number of Restricted Stock Units | Weighted Average Grant Date Fair Value | Aggregate Intrinsic Value | ||||||||||||||
Outstanding, January 1, 2022 | |||||||||||||||||
Granted | $ | ||||||||||||||||
Released (1) | ( | $ | |||||||||||||||
Forfeited | ( | ||||||||||||||||
Outstanding, March 31, 2022 | |||||||||||||||||
Outstanding, January 1, 2023 | $ | ||||||||||||||||
Granted | |||||||||||||||||
Released (1) | ( | $ | |||||||||||||||
Forfeited | ( | ||||||||||||||||
Outstanding, March 31, 2023 | |||||||||||||||||
Vested but not released, March 31, 2023 | $ | ||||||||||||||||
Three Months Ended March 31, | |||||||||||
2023 | 2022 | ||||||||||
Expected volatility | % | % | |||||||||
Risk-free interest rate | % | % | |||||||||
Expected term (years) | |||||||||||
Weighted average fair value | $ | $ |
Three Months Ended March 31, | |||||||||||
In thousands | 2023 | 2022 | |||||||||
Net interest and penalties expense | $ | $ |
In thousands | March 31, 2023 | December 31, 2022 | |||||||||
Accrued interest | $ | $ | |||||||||
Accrued penalties |
In thousands | March 31, 2023 | December 31, 2022 | |||||||||
Unrecognized tax benefits related to uncertain tax positions | $ | $ | |||||||||
The amount of unrecognized tax benefits that, if recognized, would affect our effective tax rate |
In thousands | March 31, 2023 | December 31, 2022 | |||||||||
Credit facility | |||||||||||
Multicurrency revolving line of credit | $ | $ | |||||||||
Standby LOCs issued and outstanding | ( | ( | |||||||||
Net available for additional borrowings under the multicurrency revolving line of credit | $ | $ | |||||||||
Net available for additional standby LOCs under sub-facility | $ | $ | |||||||||
Unsecured multicurrency revolving lines of credit with various financial institutions | |||||||||||
Multicurrency revolving lines of credit | $ | $ | |||||||||
Standby LOCs issued and outstanding | ( | ( | |||||||||
Short-term borrowings | |||||||||||
Net available for additional borrowings and LOCs | $ | $ | |||||||||
Unsecured surety bonds in force | $ | $ |
Three Months Ended March 31, | |||||||||||
In thousands | 2023 | 2022 | |||||||||
Beginning balance | $ | $ | |||||||||
New product warranties | |||||||||||
Other adjustments and expirations, net | ( | ||||||||||
Claims activity | ( | ( | |||||||||
Effect of change in exchange rates | ( | ||||||||||
Ending balance | |||||||||||
Less: current portion of warranty | |||||||||||
Long-term warranty | $ | $ |
Three Months Ended March 31, | |||||||||||
In thousands | 2023 | 2022 | |||||||||
Total warranty expense | $ | $ |
In thousands | Total Expected Costs at March 31, 2023 | Costs Recognized in Prior Periods | Costs Recognized During the Three Months Ended March 31, 2023 | Expected Remaining Costs to be Recognized at March 31, 2023 | |||||||||||||||||||
Employee severance costs | $ | $ | $ | $ | |||||||||||||||||||
Asset impairments & net loss (gain) on sale or disposal | |||||||||||||||||||||||
Other restructuring costs | |||||||||||||||||||||||
Total | $ | $ | $ | $ | |||||||||||||||||||
In thousands | Total Expected Costs at March 31, 2023 | Costs Recognized in Prior Periods | Adjustments Recognized During the Three Months Ended March 31, 2023 | Expected Remaining Costs to be Recognized at March 31, 2023 | |||||||||||||||||||
Employee severance costs | $ | $ | $ | ( | $ | ||||||||||||||||||
Asset impairments & net loss (gain) on sale or disposal | |||||||||||||||||||||||
Other restructuring costs | ( | ||||||||||||||||||||||
Total | $ | $ | $ | ( | $ | ||||||||||||||||||
In thousands | Total Expected Costs at March 31, 2023 | Costs Recognized in Prior Periods | Adjustments Recognized During the Three Months Ended March 31, 2023 | Expected Remaining Costs to be Recognized at March 31, 2023 | |||||||||||||||||||
Employee severance costs | $ | $ | $ | ( | $ | ||||||||||||||||||
Asset impairments & net loss (gain) on sale or disposal | |||||||||||||||||||||||
Other restructuring costs | |||||||||||||||||||||||
Total | $ | $ | $ | ( | $ | ||||||||||||||||||
In thousands | Accrued Employee Severance | Asset Impairments & Net Loss (Gain) on Sale or Disposal | Other Accrued Costs | Total | |||||||||||||||||||
Beginning balance, January 1, 2023 | $ | $ | $ | $ | |||||||||||||||||||
Costs charged to expense | |||||||||||||||||||||||
Cash payments | ( | ( | ( | ( | |||||||||||||||||||
Net assets disposed and impaired | ( | ( | |||||||||||||||||||||
Effect of change in exchange rates | |||||||||||||||||||||||
Ending balance, March 31, 2023 | $ | $ | $ | $ |
In thousands | Foreign Currency Translation Adjustments | Net Unrealized Gain (Loss) on Derivative Instruments | Net Unrealized Gain (Loss) on Nonderivative Instruments | Pension Benefit Obligation Adjustments | Accumulated Other Comprehensive Income (Loss) | ||||||||||||||||||||||||
Balances at January 1, 2022 | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||||||
OCI before reclassifications | ( | ( | |||||||||||||||||||||||||||
Amounts reclassified from AOCI | |||||||||||||||||||||||||||||
Total other comprehensive income (loss) | |||||||||||||||||||||||||||||
Balances at March 31, 2022 | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||||||
Balances at January 1, 2023 | $ | ( | $ | ( | $ | ( | $ | $ | ( | ||||||||||||||||||||
OCI before reclassifications | |||||||||||||||||||||||||||||
Amounts reclassified from AOCI | ( | ( | |||||||||||||||||||||||||||
Total other comprehensive income (loss) | ( | ||||||||||||||||||||||||||||
Balances at March 31, 2023 | $ | ( | $ | ( | $ | ( | $ | $ | ( |
Three Months Ended March 31, | |||||||||||
In thousands | 2023 | 2022 | |||||||||
Before-tax amount | |||||||||||
Foreign currency translation adjustment | $ | $ | ( | ||||||||
Foreign currency translation adjustment reclassified to net income (loss) on sale of business | |||||||||||
Net unrealized gain (loss) on defined benefit plans | |||||||||||
Net defined benefit plan (gain) loss reclassified to net income (loss) | ( | ||||||||||
Total other comprehensive income (loss), before tax | $ | $ | |||||||||
Tax (provision) benefit | |||||||||||
Foreign currency translation adjustment | $ | ( | $ | ( | |||||||
Foreign currency translation adjustment reclassified to net income (loss) on sale of business | |||||||||||
Net unrealized gain (loss) on defined benefit plans | ( | ||||||||||
Net defined benefit plan (gain) loss reclassified to net income (loss) | |||||||||||
Total other comprehensive income (loss) tax (provision) benefit | $ | ( | $ | ( | |||||||
Net-of-tax amount | |||||||||||
Foreign currency translation adjustment | $ | $ | ( | ||||||||
Foreign currency translation adjustment reclassified to net income (loss) on sale of business | |||||||||||
Net unrealized gain (loss) on defined benefit plans | |||||||||||
Net defined benefit plan (gain) loss reclassified to net income (loss) | ( | ||||||||||
Total other comprehensive income (loss), net of tax | $ | $ |
March 31, 2023 | December 31, 2022 | ||||||||||||||||||||||
In thousands | Carrying Amount | Fair Value | Carrying Amount | Fair Value | |||||||||||||||||||
Credit facility | |||||||||||||||||||||||
Multicurrency revolving line of credit | $ | $ | $ | $ | |||||||||||||||||||
Convertible notes | |||||||||||||||||||||||
Three Months Ended March 31, | |||||||||||
In thousands | 2023 | 2022 | |||||||||
Product revenues | |||||||||||
Device Solutions | $ | $ | |||||||||
Networked Solutions | |||||||||||
Outcomes | |||||||||||
Total Company | $ | $ | |||||||||
Service revenues | |||||||||||
Device Solutions | $ | $ | |||||||||
Networked Solutions | |||||||||||
Outcomes | |||||||||||
Total Company | $ | $ | |||||||||
Total revenues | |||||||||||
Device Solutions | $ | $ | |||||||||
Networked Solutions | |||||||||||
Outcomes | |||||||||||
Total Company | $ | $ | |||||||||
Gross profit | |||||||||||
Device Solutions | $ | $ | |||||||||
Networked Solutions | |||||||||||
Outcomes | |||||||||||
Total Company | $ | $ | |||||||||
Operating income (loss) | |||||||||||
Device Solutions | $ | $ | |||||||||
Networked Solutions | |||||||||||
Outcomes | |||||||||||
Corporate unallocated | ( | ( | |||||||||
Total Company | ( | ||||||||||
Total other income (expense) | ( | ( | |||||||||
Income (loss) before income taxes | $ | ( | $ |
Three Months Ended March 31, | |||||||||||
In thousands | 2023 | 2022 | |||||||||
United States and Canada | $ | $ | |||||||||
Europe, Middle East, and Africa | |||||||||||
Asia Pacific | |||||||||||
Total Company | $ | $ |
Three Months Ended March 31, | |||||||||||
In thousands | 2023 | 2022 | |||||||||
Device Solutions | $ | $ | |||||||||
Networked Solutions | |||||||||||
Outcomes | |||||||||||
Corporate unallocated | |||||||||||
Total Company | $ | $ |
In thousands | Contract Liabilities, Less Contract Assets | ||||
Beginning balance, January 1, 2023 | $ | ||||
Revenues recognized from beginning contract liability | ( | ||||
Cumulative catch-up adjustments | |||||
Increases due to amounts collected or due | |||||
Revenues recognized from current period increases | ( | ||||
Other | |||||
Ending balance, March 31, 2023 | $ | ||||
Three Months Ended March 31, | |||||||||||||||||
In thousands, except margin and per share data | 2023 | 2022 | % Change | ||||||||||||||
GAAP | |||||||||||||||||
Revenues | |||||||||||||||||
Product revenues | $ | 416,324 | $ | 399,810 | 4% | ||||||||||||
Service revenues | 78,294 | 75,521 | 4% | ||||||||||||||
Total revenues | 494,618 | 475,331 | 4% | ||||||||||||||
Gross profit | 156,368 | 135,224 | 16% | ||||||||||||||
Operating expenses | 166,761 | 128,405 | 30% | ||||||||||||||
Operating income (loss) | (10,393) | 6,819 | NM | ||||||||||||||
Other income (expense) | (1,714) | (2,064) | (17)% | ||||||||||||||
Income tax benefit (provision) | 70 | (3,859) | NM | ||||||||||||||
Net income (loss) attributable to Itron, Inc. | (11,836) | 906 | NM | ||||||||||||||
Non-GAAP(1) | |||||||||||||||||
Non-GAAP operating expenses | $ | 125,041 | $ | 125,935 | (1)% | ||||||||||||
Non-GAAP operating income | 31,327 | 9,289 | 237% | ||||||||||||||
Non-GAAP net income attributable to Itron, Inc. | 22,382 | 5,171 | 333% | ||||||||||||||
Adjusted EBITDA | 39,468 | 18,894 | 109% | ||||||||||||||
GAAP Margins and Earnings Per Share | |||||||||||||||||
Gross margin | |||||||||||||||||
Product gross margin | 28.6 | % | 26.3 | % | |||||||||||||
Service gross margin | 47.8 | % | 40.0 | % | |||||||||||||
Total gross margin | 31.6 | % | 28.4 | % | |||||||||||||
Operating margin | (2.1) | % | 1.4 | % | |||||||||||||
Net income (loss) per common share - Basic | $ | (0.26) | $ | 0.02 | |||||||||||||
Net income (loss) per common share - Diluted | $ | (0.26) | $ | 0.02 | |||||||||||||
Non-GAAP Earnings Per Share(1) | |||||||||||||||||
Non-GAAP diluted EPS | $ | 0.49 | $ | 0.11 | |||||||||||||
As of March 31, | |||||||||||
Units in thousands | 2023 | 2022 | |||||||||
Endpoints under management | 92,410 | 83,156 |
Effect of Changes in Foreign Currency Exchange Rates | Constant Currency Change | Total Change | ||||||||||||||||||||||||||||||
Three Months Ended March 31, | ||||||||||||||||||||||||||||||||
In thousands | 2023 | 2022 | ||||||||||||||||||||||||||||||
Total Company | ||||||||||||||||||||||||||||||||
Revenues | $ | 494,618 | $ | 475,331 | $ | (8,731) | $ | 28,018 | $ | 19,287 | ||||||||||||||||||||||
Gross profit | 156,368 | 135,224 | (2,145) | 23,289 | 21,144 |
Effect of Changes in Foreign Currency Exchange Rates | Constant Currency Change | Total Change | ||||||||||||||||||||||||||||||
Three Months Ended March 31, | ||||||||||||||||||||||||||||||||
In thousands | 2023 | 2022 | ||||||||||||||||||||||||||||||
Total Company | ||||||||||||||||||||||||||||||||
Sales, general and administrative | $ | 75,521 | $ | 76,401 | $ | (980) | $ | 100 | $ | (880) | ||||||||||||||||||||||
Research and development | 49,565 | 49,596 | (504) | 473 | (31) | |||||||||||||||||||||||||||
Amortization of intangible assets | 5,048 | 6,553 | (81) | (1,424) | (1,505) | |||||||||||||||||||||||||||
Restructuring | 36,609 | (6,366) | 6 | 42,969 | 42,975 | |||||||||||||||||||||||||||
Loss on sale of business | 18 | 2,221 | 2,517 | (4,720) | (2,203) | |||||||||||||||||||||||||||
Total operating expenses | $ | 166,761 | $ | 128,405 | $ | 958 | $ | 37,398 | $ | 38,356 |
Three Months Ended March 31, | % Change | ||||||||||||||||
In thousands | 2023 | 2022 | |||||||||||||||
Interest income | $ | 1,818 | $ | 217 | NM | ||||||||||||
Amortization of prepaid debt fees | (889) | (839) | 6% | ||||||||||||||
Other interest expense | (1,168) | (753) | 55% | ||||||||||||||
Interest expense | (2,057) | (1,592) | 29% | ||||||||||||||
Other income (expense), net | (1,475) | (689) | NM | ||||||||||||||
Total other income (expense) | $ | (1,714) | $ | (2,064) | (17)% |
Three Months Ended March 31, | |||||||||||||||||||||||
In thousands | 2023 | 2022 | % Change | ||||||||||||||||||||
Segment revenues | |||||||||||||||||||||||
Device Solutions | $ | 118,254 | $ | 139,565 | (15)% | ||||||||||||||||||
Networked Solutions | 313,468 | 278,820 | 12% | ||||||||||||||||||||
Outcomes | 62,896 | 56,946 | 10% | ||||||||||||||||||||
Total revenues | $ | 494,618 | $ | 475,331 | 4% | ||||||||||||||||||
Three Months Ended March 31, | |||||||||||||||||||||||
2023 | 2022 | ||||||||||||||||||||||
In thousands | Gross Profit | Gross Margin | Gross Profit | Gross Margin | |||||||||||||||||||
Segment gross profit and margin | |||||||||||||||||||||||
Device Solutions | $ | 23,713 | 20.1% | $ | 21,806 | 15.6% | |||||||||||||||||
Networked Solutions | 105,776 | 33.7% | 91,351 | 32.8% | |||||||||||||||||||
Outcomes | 26,879 | 42.7% | 22,067 | 38.8% | |||||||||||||||||||
Total gross profit and margin | $ | 156,368 | 31.6% | $ | 135,224 | 28.4% | |||||||||||||||||
Three Months Ended March 31, | |||||||||||||||||||||||
In thousands | 2023 | 2022 | % Change | ||||||||||||||||||||
Segment operating expenses | |||||||||||||||||||||||
Device Solutions | $ | 9,635 | $ | 10,228 | (6)% | ||||||||||||||||||
Networked Solutions | 30,820 | 30,344 | 2% | ||||||||||||||||||||
Outcomes | 13,968 | 13,726 | 2% | ||||||||||||||||||||
Corporate unallocated | 112,338 | 74,107 | 52% | ||||||||||||||||||||
Total operating expenses | $ | 166,761 | $ | 128,405 | 30% | ||||||||||||||||||
Three Months Ended March 31, | |||||||||||||||||||||||
2023 | 2022 | ||||||||||||||||||||||
In thousands | Operating Income (Loss) | Operating Margin | Operating Income (Loss) | Operating Margin | |||||||||||||||||||
Segment operating income (loss) and operating margin | |||||||||||||||||||||||
Device Solutions | $ | 14,078 | 11.9% | $ | 11,578 | 8.3% | |||||||||||||||||
Networked Solutions | 74,956 | 23.9% | 61,007 | 21.9% | |||||||||||||||||||
Outcomes | 12,911 | 20.5% | 8,341 | 14.6% | |||||||||||||||||||
Corporate unallocated | (112,338) | NM | (74,107) | NM | |||||||||||||||||||
Total operating income (loss) and operating margin | $ | (10,393) | (2.1)% | $ | 6,819 | 1.4% |
Effect of Changes in Foreign Currency Exchange Rates | Constant Currency Change | Total Change | ||||||||||||||||||||||||||||||
Three Months Ended March 31, | ||||||||||||||||||||||||||||||||
In thousands | 2023 | 2022 | ||||||||||||||||||||||||||||||
Device Solutions Segment | ||||||||||||||||||||||||||||||||
Revenues | $ | 118,254 | $ | 139,565 | $ | (6,014) | $ | (15,297) | $ | (21,311) | ||||||||||||||||||||||
Gross profit | 23,713 | 21,806 | (803) | 2,710 | 1,907 | |||||||||||||||||||||||||||
Operating expenses | 9,635 | 10,228 | (115) | (478) | (593) |
Effect of Changes in Foreign Currency Exchange Rates | Constant Currency Change | Total Change | ||||||||||||||||||||||||||||||
Three Months Ended March 31, | ||||||||||||||||||||||||||||||||
In thousands | 2023 | 2022 | ||||||||||||||||||||||||||||||
Networked Solutions Segment | ||||||||||||||||||||||||||||||||
Revenues | $ | 313,468 | $ | 278,820 | $ | (1,620) | $ | 36,268 | $ | 34,648 | ||||||||||||||||||||||
Gross profit | 105,776 | 91,351 | (764) | 15,189 | 14,425 | |||||||||||||||||||||||||||
Operating expenses | 30,820 | 30,344 | (31) | 507 | 476 |
Effect of Changes in Foreign Currency Exchange Rates | Constant Currency Change | Total Change | ||||||||||||||||||||||||||||||
Three Months Ended March 31, | ||||||||||||||||||||||||||||||||
In thousands | 2023 | 2022 | ||||||||||||||||||||||||||||||
Outcomes Segment | ||||||||||||||||||||||||||||||||
Revenues | $ | 62,896 | $ | 56,946 | $ | (1,096) | $ | 7,046 | $ | 5,950 | ||||||||||||||||||||||
Gross profit | 26,879 | 22,067 | (578) | 5,390 | 4,812 | |||||||||||||||||||||||||||
Operating expenses | 13,968 | 13,726 | (18) | 260 | 242 |
Quarter Ended | Quarterly Bookings | Ending Total Backlog | Ending 12-Month Backlog | ||||||||||||||
In millions | |||||||||||||||||
March 31, 2023 | $ | 428 | $ | 4,558 | $ | 1,897 | |||||||||||
December 31, 2022 | 898 | 4,619 | 2,052 | ||||||||||||||
September 30, 2022 | 578 | 4,201 | 1,612 | ||||||||||||||
June 30, 2022 | 612 | 4,063 | 1,746 | ||||||||||||||
March 31, 2022 | 417 | 3,897 | 1,557 |
Three Months Ended March 31, | |||||||||||
In thousands | 2023 | 2022 | |||||||||
Net cash provided by operating activities | $ | 1,429 | $ | 7,591 | |||||||
Net cash provided by (used in) investing activities | (7,658) | 50,949 | |||||||||
Net cash used in financing activities | (95) | (17,105) | |||||||||
Effect of foreign exchange rate changes on cash and cash equivalents | 330 | (17) | |||||||||
Increase (decrease) in cash and cash equivalents | $ | (5,994) | $ | 41,418 |
Three Months Ended March 31, | |||||||||||
In thousands | 2023 | 2022 | |||||||||
Net cash provided by operating activities | $ | 1,429 | $ | 7,591 | |||||||
Acquisitions of property, plant, and equipment | (6,902) | (5,369) | |||||||||
Free cash flow | $ | (5,473) | $ | 2,222 |
TOTAL COMPANY RECONCILIATIONS | Three Months Ended March 31, | |||||||||||||||||||
In thousands, except per share data | 2023 | 2022 | ||||||||||||||||||
NON-GAAP OPERATING EXPENSES | ||||||||||||||||||||
GAAP operating expenses | $ | 166,761 | $ | 128,405 | ||||||||||||||||
Amortization of intangible assets | (5,048) | (6,553) | ||||||||||||||||||
Restructuring | (36,609) | 6,366 | ||||||||||||||||||
Loss on sale of business | (18) | (2,221) | ||||||||||||||||||
Acquisition and integration | (45) | (62) | ||||||||||||||||||
Non-GAAP operating expenses | $ | 125,041 | $ | 125,935 | ||||||||||||||||
NON-GAAP OPERATING INCOME | ||||||||||||||||||||
GAAP operating income (loss) | $ | (10,393) | $ | 6,819 | ||||||||||||||||
Amortization of intangible assets | 5,048 | 6,553 | ||||||||||||||||||
Restructuring | 36,609 | (6,366) | ||||||||||||||||||
Loss on sale of business | 18 | 2,221 | ||||||||||||||||||
Acquisition and integration | 45 | 62 | ||||||||||||||||||
Non-GAAP operating income | $ | 31,327 | $ | 9,289 | ||||||||||||||||
NON-GAAP NET INCOME & DILUTED EPS | ||||||||||||||||||||
GAAP net income (loss) attributable to Itron, Inc. | $ | (11,836) | $ | 906 | ||||||||||||||||
Amortization of intangible assets | 5,048 | 6,553 | ||||||||||||||||||
Amortization of debt placement fees | 845 | 796 | ||||||||||||||||||
Restructuring | 36,609 | (6,366) | ||||||||||||||||||
Loss on sale of business | 18 | 2,221 | ||||||||||||||||||
Acquisition and integration | 45 | 62 | ||||||||||||||||||
Income tax effect of non-GAAP adjustments | (8,347) | 999 | ||||||||||||||||||
Non-GAAP net income attributable to Itron, Inc. | $ | 22,382 | $ | 5,171 | ||||||||||||||||
Non-GAAP diluted EPS | $ | 0.49 | $ | 0.11 | ||||||||||||||||
Non-GAAP weighted average common shares outstanding - Diluted | 45,572 | 45,240 | ||||||||||||||||||
TOTAL COMPANY RECONCILIATIONS | Three Months Ended March 31, | |||||||||||||||||||
In thousands, except per share data | 2023 | 2022 | ||||||||||||||||||
ADJUSTED EBITDA | ||||||||||||||||||||
GAAP net income (loss) attributable to Itron, Inc. | $ | (11,836) | $ | 906 | ||||||||||||||||
Interest income | (1,818) | (217) | ||||||||||||||||||
Interest expense | 2,057 | 1,592 | ||||||||||||||||||
Income tax provision (benefit) | (70) | 3,859 | ||||||||||||||||||
Depreciation and amortization | 14,463 | 16,837 | ||||||||||||||||||
Restructuring | 36,609 | (6,366) | ||||||||||||||||||
Loss on sale of business | 18 | 2,221 | ||||||||||||||||||
Acquisition and integration | 45 | 62 | ||||||||||||||||||
Adjusted EBITDA | $ | 39,468 | $ | 18,894 | ||||||||||||||||
FREE CASH FLOW | ||||||||||||||||||||
Net cash provided by operating activities | $ | 1,429 | $ | 7,591 | ||||||||||||||||
Acquisitions of property, plant, and equipment | (6,902) | (5,369) | ||||||||||||||||||
Free Cash Flow | $ | (5,473) | $ | 2,222 |
Period | Total Number of Shares Purchased (1) | Average Price Paid per Share (2) | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Maximum Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs | |||||||||||||||||||
In thousands | |||||||||||||||||||||||
January 1, 2023 through January 31, 2023 | — | $ | — | — | $ | 75,000 | |||||||||||||||||
February 1, 2023 through February 28, 2023 | — | — | — | 75,000 | |||||||||||||||||||
March 1, 2023 through March 31, 2023 | — | — | — | 75,000 | |||||||||||||||||||
Total | — | — |
Exhibit Number | Description of Exhibits | |||||||
31.1 | ||||||||
31.2 | ||||||||
32.1 | ||||||||
101 | The following financial information from Itron, Inc.'s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 formatted in Inline XBRL (Extensible Business Reporting Language) includes: (i) the Consolidated Statements of Operations, (ii) the Consolidated Statements of Comprehensive Income (Loss), (iii) the Consolidated Balance Sheets, (iv) the Consolidated Statements of Equity, (v) the Consolidated Statements of Cash Flows, and (vi) Notes to the Consolidated Financial Statements. | |||||||
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | |||||||
ITRON, INC. | |||||||||||
May 4, 2023 | By: | /s/ JOAN S. HOOPER | |||||||||
Date | Joan S. Hooper | ||||||||||
Senior Vice President and Chief Financial Officer |
ITRON, INC. | |||||||||||
By: | /s/ THOMAS L. DEITRICH | ||||||||||
Thomas L. Deitrich President and Chief Executive Officer |
ITRON, INC. | |||||||||||
By: | /s/ JOAN S. HOOPER | ||||||||||
Joan S. Hooper Senior Vice President and Chief Financial Officer |
/s/ THOMAS L. DEITRICH | May 4, 2023 | |||||||
Thomas L. Deitrich President and Chief Executive Officer | Date | |||||||
/s/ JOAN S. HOOPER | May 4, 2023 | |||||||
Joan S. Hooper Senior Vice President and Chief Financial Officer | Date | |||||||
Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2023 |
Mar. 31, 2022 |
|
Statement of Comprehensive Income [Abstract] | ||
Net income (loss) | $ (12,037) | $ 896 |
Other comprehensive income (loss), net of tax: | ||
Foreign currency translation adjustments | 7,225 | (6,891) |
Foreign currency translation adjustment reclassified to net income (loss) on sale of business | 0 | 55,436 |
Pension benefit obligation adjustment | (106) | 4,270 |
Total other comprehensive income (loss), net of tax | 7,119 | 52,815 |
Total comprehensive income (loss), net of tax | (4,918) | 53,711 |
Comprehensive loss attributable to noncontrolling interests, net of tax | (201) | (10) |
Comprehensive income (loss) attributable to Itron, Inc. | $ (4,717) | $ 53,721 |
Consolidated Balance Sheets (Parenthetical) - $ / shares |
Mar. 31, 2023 |
Dec. 31, 2022 |
---|---|---|
Statement of Financial Position [Abstract] | ||
Preferred stock, no par value (in dollars per share) | $ 0 | $ 0 |
Preferred stock, shares authorized (in share) | 10,000,000 | 10,000,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Common stock, shares authorized (in shares) | 75,000,000 | 75,000,000 |
Common stock, shares issued (in shares) | 45,405,000 | 45,186,000 |
Common stock, shares outstanding (in shares) | 45,405,000 | 45,186,000 |
Summary of Significant Accounting Policies |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies Financial Statement Preparation The consolidated financial statements presented in this Quarterly Report on Form 10-Q are unaudited and reflect entries necessary for the fair presentation of the Consolidated Statements of Operations and the Consolidated Statements of Comprehensive Income (Loss) for the three months ended March 31, 2023 and 2022, Consolidated Statements of Equity for the three months ended March 31, 2023 and 2022, the Consolidated Statements of Cash Flows for the three months ended March 31, 2023 and 2022, and the Consolidated Balance Sheets as of March 31, 2023 and December 31, 2022, of Itron, Inc. and its subsidiaries. All entries required for the fair presentation of the financial statements are of a normal recurring nature, except as disclosed. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results expected for the full year or for any other period. Certain information and notes normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (GAAP) have been partially or completely omitted pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC) regarding interim results. These consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto for the fiscal year ended December 31, 2022 filed with the SEC in our Annual Report on Form 10-K on February 27, 2023 (2022 Annual Report). There have been no significant changes in financial statement preparation or significant accounting policies since December 31, 2022. Risks and Uncertainties The pandemic has resulted in global economic impacts including disrupting customer demand and global supply chains, resulting in market volatility, which our management continues to monitor. As economies have reopened, global supply chains have struggled to keep pace with rapidly changing demand. The resulting supply constraints have manifested across a variety of areas including mechanical, electrical, and logistics portions of the supply chain, which has impacted our ability to ship products in a timely manner. In particular, our ability to obtain adequate supply of semiconductor components has impacted our ability to service recovering customer demand. While we believe the current imbalance in supply and demand is temporal, the timeline to recovery is uncertain. Efforts are ongoing with suppliers to increase supply, including the approval of alternate sources. Recently, inflation in our raw materials and component costs, freight charges, and labor costs have increased above historical levels, due to, among other things, the continuing impacts of the uncertain economic environment. We may or may not be able to fully recover these increased costs through pricing actions with our customers. At this time, we have not identified any significant decrease in long-term customer demand for our products and services. However, certain of our customer projects have experienced delay in deliveries, with revenues originally forecasted in prior periods shifting to future periods. While we have limited direct business exposure in Russia, Belarus and Ukraine, the Russian military actions and the resulting sanctions could adversely affect the global economy, as well as further disrupt the supply chain. A major disruption in the global economy and supply chain could have a material adverse effect on our business, prospects, financial condition, results of operations, and cash flows. The extent and duration of the military action, sanctions, and resulting market and/or supply disruptions are impossible to predict, but could be substantial, and our management continues to monitor these events closely. Reclassification In the Consolidated Statements of Cash Flows, the following reclassifications have been made to prior year amounts to conform to current year presentation of restructuring liabilities:
Recently Adopted Accounting Standards In October 2021, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2021-08 amending Business Combination: (Topic 805), which was necessary due to 2014-09, Revenue from Contracts with Customers (Topic 606). The FASB issued this Update to improve the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to (1) recognition of an acquired contract liability and (2) payment terms and their effect on subsequent revenue recognized by the acquirer. We adopted this amendment as of the effective date of January 1, 2023. These amendments are to be applied prospectively to business combinations occurring on or after the effective date of the amendments. We currently plan to apply the practical expedients as needed for any future acquisitions. The practical expedients cover contracts that were modified prior to acquisition date as well as determining which date an acquirer would have to determine the standalone selling price of each performance obligation in an acquired contract.
|
Earnings Per Share |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share | Earnings Per Share The following table sets forth the computation of basic and diluted earnings per share (EPS):
Stock-based Awards For stock-based awards, the dilutive effect is calculated using the treasury stock method. Under this method, the dilutive effect is computed as if the awards were exercised at the beginning of the period (or at time of issuance, if later) and assumes the related proceeds were used to repurchase our common stock at the average market price during the period. Related proceeds include the amount the employee must pay upon exercise and the future compensation cost associated with the stock award. Approximately 0.7 million and 0.4 million stock-based awards were excluded from the calculation of diluted EPS for the three months ended March 31, 2023 and 2022 because they were anti-dilutive. These stock-based awards could be dilutive in future periods. Convertible Notes and Warrants For our convertible notes issued in March 2021, the dilutive effect is calculated using the if-converted method. We are required, pursuant to the indenture governing our convertible notes, to settle the principal amount of the convertible notes in cash and may elect to settle the remaining conversion obligation (stock price in excess of conversion price) in cash, shares, or a combination thereof. Under the if-converted method, we include the number of shares required to satisfy the remaining conversion obligation, assuming all the convertible notes were converted. The average closing prices of our common stock for the quarter ended March 31, 2023 were used as the basis for determining the dilutive effect on EPS. The quarterly average closing prices for our common stock did not exceed the conversion price of $126.00, and therefore all associated shares were anti-dilutive. In conjunction with the issuance of the convertible notes, we sold warrants to purchase 3.7 million shares of Itron common stock. The warrants have a strike price of $180.00 per share. For calculating the dilutive effect of the warrants, we use the treasury stock method. With this method, we assume exercise of the warrants at the beginning of the period, or at time of issuance if later, and the issuance of common stock upon exercise. Proceeds from the exercise of the warrants are assumed to be used to repurchase shares of our stock at the average market price during the period. The incremental shares, representing the number of shares assumed to be exercised with the warrants less the number of shares repurchased, are included in diluted weighted average common shares outstanding. For periods where the warrants strike price of $180.00 per share is greater than the average share price of Itron stock for the period, the warrants would be anti-dilutive. For the three months ended March 31, 2023, the quarterly average closing prices of our common stock did not exceed the warrant strike price and therefore 3.7 million shares were considered anti-dilutive. Convertible Note Hedge Transactions In connection with the issuance of the convertible notes, we entered into privately negotiated call option contracts on our common stock (the convertible note hedge transactions) with certain commercial banks (the Counterparties). The convertible note hedge transactions cover, subject to anti-dilution adjustments substantially similar to those in the convertible notes, approximately 3.7 million shares of our common stock, the same number of shares initially underlying the convertible notes, at a strike price of approximately $126.00, subject to customary adjustments. The convertible note hedge transactions will expire upon the maturity of the convertible notes, subject to earlier exercise or termination. Exercise of the convertible note hedge transactions would reduce the number of shares of our common stock outstanding and therefore would be anti-dilutive.
|
Certain Balance Sheet Components |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance Sheet Related Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Certain Balance Sheet Components | Certain Balance Sheet Components A summary of accounts receivable from contracts with customers is as follows:
|
Intangible Assets and Liabilities |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Intangible Assets, Net (Excluding Goodwill) [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Intangible Assets and Liabilities | Intangible Assets and Liabilities The gross carrying amount and accumulated amortization (accretion) of our intangible assets and liabilities, other than goodwill, were as follows:
A summary of intangible assets and liabilities activity is as follows:
Assumed intangible liabilities reflect the present value of the projected cash outflows for an existing contract where remaining costs are expected to exceed projected revenues. Estimated future annual amortization is as follows:
|
Goodwill |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill Excluding Non Goodwill Intangibles [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill | Goodwill The following table reflects changes in the carrying amount of goodwill for the three months ended March 31, 2023:
|
Debt |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt | Debt The components of our borrowings were as follows:
Credit Facility Our current credit facility, initially entered on January 5, 2018 (as amended, the 2018 credit facility), originally provided for committed credit facilities in the amount of $1.2 billion U.S. dollars. This facility now consists of a multicurrency revolving line of credit (the revolver) with a principal amount of up to $500 million. The revolver also contains a $300 million standby letter of credit sub-facility and a $50 million swingline sub-facility. The $650 million U.S. dollar term loan included in the original facility was fully repaid in August 2021. The 2018 credit facility permits us and certain of our foreign subsidiaries to borrow in U.S. dollars, euros, or, with lender approval, other currencies readily convertible into U.S. dollars. All obligations under the 2018 credit facility are guaranteed by Itron, Inc. and material U.S. domestic subsidiaries and are secured by a pledge of substantially all of the assets of Itron, Inc. and material U.S. domestic subsidiaries. This includes a pledge of 100% of the capital stock of material U.S. domestic subsidiaries and up to 66% of the voting stock (100% of the non-voting stock) of first-tier foreign subsidiaries. In addition, the obligations of any foreign subsidiary who is a foreign borrower, as defined by the 2018 credit facility, are guaranteed by the foreign subsidiary and by its direct and indirect foreign parents. The 2018 credit facility includes debt covenants, which contain certain financial thresholds and place certain restrictions on the incurrence of debt, investments, and the issuance of dividends. We were in compliance with the debt covenants under the 2018 credit facility at March 31, 2023. Under the 2018 credit facility, we elect applicable market interest rates for both the term loan and any outstanding revolving loans. We also pay an applicable margin, which is based on our total net leverage ratio as defined in the credit agreement. The applicable rates per annum may be based on either: (1) the LIBOR rate or EURIBOR rate (subject to a floor of 0%), plus an applicable margin, or (2) the Alternate Base Rate, plus an applicable margin. The Alternate Base Rate election is equal to the greatest of three rates: (i) the prime rate, (ii) the Federal Reserve effective rate plus 0.50%, or (iii) one-month LIBOR plus 1.00%. The cessation of LIBOR will occur in June 2023. On November 23, 2022, we amended the 2018 credit facility to replace the LIBOR rate with the Term Secured Overnight Financing Rate (SOFR) as the base interest rate. On February 21, 2023, we entered into a sixth amendment to the 2018 credit facility. This amendment modifies provisions to allow for the addback for debt covenant calculations of non-recurring cash expenses related to restructuring charges to be incurred during the quarter ended March 31, 2023. At March 31, 2023, there were no outstanding loan balances under the credit facility, and $62.1 million was utilized by outstanding standby letters of credit, resulting in $437.9 million available for additional borrowings or standby letters of credit within the revolver. At March 31, 2023, $237.9 million was available for additional standby letters of credit under the letter of credit sub-facility, and no amounts were outstanding under the swingline sub-facility. Convertible Notes On March 12, 2021, we closed the sale of the convertible notes in a private placement to qualified institutional buyers, resulting in net proceeds to us of $448.5 million after deducting initial purchasers’ discounts of the offering. The convertible notes do not bear regular interest, and the principal amount does not accrete. The convertible notes will mature on March 15, 2026, unless earlier repurchased, redeemed, or converted in accordance with their terms. No sinking fund is provided for the convertible notes. The initial conversion rate of the convertible notes is 7.9365 shares of our common stock per $1,000 principal amount of notes, which is equivalent to an initial conversion price of approximately $126.00 per share. The conversion rate of the convertible notes is subject to adjustment upon the occurrence of certain specified events. In addition, upon the occurrence of a make-whole fundamental change (as defined in the indenture governing the convertible notes) or upon a notice of redemption, we will, in certain circumstances, increase the conversion rate for a holder that elects to convert its convertible notes in connection with such make-whole fundamental change or notice of redemption, as the case may be. Prior to the close of business on the business day immediately preceding December 15, 2025, the convertible notes are convertible at the option of the holders only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on June 30, 2021 (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five business-day period after any five consecutive trading-day period (the measurement period) in which the trading price per $1,000 principal amount of convertible notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the common stock and the conversion rate on each such trading day; (3) upon the occurrence of specified corporate events; or (4) upon redemption by us. On or after December 15, 2025, until the close of business on the second scheduled trading day immediately preceding March 15, 2026, holders of the convertible notes may convert all or a portion of their notes at any time. Upon conversion, we will pay cash up to the aggregate principal amount of convertible notes to be converted and pay and/or deliver, as the case may be, cash, shares of common stock or a combination of cash and shares of common stock, at our election, in respect of the remainder, if any, of our conversion obligation in excess of the aggregate principal amount of the convertible notes being converted. On or after March 20, 2024 and prior to December 15, 2025, we may redeem for cash all or part of the convertible notes, at our option, if the last reported sales price of common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive), including the trading day immediately preceding the date on which we provide notice of redemption, during any 30 consecutive trading days ending on, and including, the trading day immediately before the date we send the related notice of the redemption. The redemption price of each convertible notes to be redeemed will be the principal amount of such note, plus accrued and unpaid special interest, if any. Upon the occurrence of a fundamental change (as defined in the indenture governing the convertible notes), subject to a limited exception described in the indenture governing the convertible notes, holders may require us to repurchase all or a portion of their notes for cash at a price equal to plus accrued and unpaid special interest to, but not including, the fundamental change repurchase date (as defined in the indenture governing the convertible notes). The convertible notes are senior unsecured obligations and rank equally in right of payment with all of our existing and future unsubordinated debt and senior in right of payment to any future debt that is expressly subordinated in right of payment to the convertible notes. The convertible notes will be effectively subordinated to any of our existing and future secured debt to the extent of the assets securing such indebtedness. The convertible notes will be structurally subordinated to all existing debt and any future debt and any other liabilities of our subsidiaries. Debt Maturities The amount of required minimum principal payments on our long-term debt in aggregate over the next five years is as follows:
|
Derivative Financial Instruments |
3 Months Ended |
---|---|
Mar. 31, 2023 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivative Financial Instruments | Derivative Financial Instruments As part of our risk management strategy, we use derivative instruments to hedge certain foreign currencies. Refer to Note 13: Shareholders' Equity and Note 14: Fair Value of Financial Instruments for additional disclosures on our derivative instruments. Derivatives Not Designated as Hedging Relationships We are exposed to foreign exchange risk when we enter into non-functional currency transactions, both intercompany and third party. At each period-end, non-functional currency monetary assets and liabilities are revalued with the change recognized within other income (expense) in our Consolidated Statements of Operations. We enter into monthly foreign exchange forward contracts, which are not designated for hedge accounting, with the intent to reduce earnings volatility associated with currency exposures. As of March 31, 2023, a total of 38 contracts were offsetting our exposures from the euro, pound sterling, Indonesian rupiah, Canadian dollar, Australian dollar and various other currencies, with notional amounts ranging from $115,000 to $47.0 million. We will continue to monitor and assess our interest rate and foreign exchange risk and may institute additional derivative instruments to manage such risk in the future.
|
Defined Benefit Pension Plans |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Retirement Benefits [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Defined Benefit Pension Plans | Defined Benefit Pension Plans We sponsor both funded and unfunded defined benefit pension plans offering death and disability, retirement, and special termination benefits for certain of our international employees, primarily in Germany, France, Indonesia, India, and Italy. The defined benefit obligation is calculated annually by using the projected unit credit method. The measurement date for the pension plans was December 31, 2022. Amounts recognized on the Consolidated Balance Sheets consist of:
Our asset investment strategy focuses on maintaining a portfolio using primarily insurance funds, which are accounted for as investments and measured at fair value, in order to achieve our long-term investment objectives on a risk-adjusted basis. Our general funding policy for these qualified pension plans is to contribute amounts sufficient to satisfy regulatory funding standards of the respective countries for each plan. Net periodic pension benefit cost for our plans includes the following components:
The components of net periodic benefit cost, other than the service cost component, are included in total other income (expense) on the Consolidated Statements of Operations.
|
Stock-Based Compensation |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-Based Payment Arrangement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock-Based Compensation | Stock-Based Compensation We grant stock-based compensation awards, including restricted stock units, phantom stock, and unrestricted stock units, under the Second Amended and Restated 2010 Stock Incentive Plan (Stock Incentive Plan). Prior to December 31, 2020, stock options were also granted as part of the stock-based compensation awards. In the Stock Incentive Plan, we have 12,623,538 shares of common stock reserved and authorized for issuance subject to stock splits, dividends, and other similar events, and at March 31, 2023, 3,969,520 shares were available for grant. We issue new shares of common stock upon the exercise of stock options or when vesting conditions on restricted stock units are fully satisfied. These shares are subject to a fungible share provision such that the authorized share available for grant is reduced by (i) one share for every one share subject to a stock option or share appreciation right granted under the Plan and (ii) 1.7 shares for every one share of common stock that was subject to an award other than an option or share appreciation right. We also award phantom stock units, which are settled in cash upon vesting and accounted for as liability-based awards, with no impact to the shares available for grant. In addition, we maintain the Employee Stock Purchase Plan (ESPP), for which 58,633 shares of common stock were available for future issuance at March 31, 2023. ESPP activity and stock-based grants other than stock options and restricted stock units were not significant for the three months ended March 31, 2023 and 2022. Stock-Based Compensation Expense Total stock-based compensation expense and the related tax benefit were as follows:
Stock Options A summary of our stock option activity is as follows:
At March 31, 2023, total unrecognized stock-based compensation expense related to nonvested stock options was $42,000, which is expected to be recognized over a weighted average period of approximately 0.6 years. Restricted Stock Units The following table summarizes restricted stock unit activity:
(1) Shares released is presented as gross shares and does not reflect shares withheld by us for employee payroll tax obligations. At March 31, 2023, total unrecognized compensation expense on restricted stock units was $47.9 million, which is expected to be recognized over a weighted average period of approximately 2.0 years. The weighted average assumptions used to estimate the fair value of performance-based restricted stock units granted with a service and market condition and the resulting weighted average fair value are as follows:
|
Income Taxes |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Tax Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Taxes | Income Taxes We determine the interim tax benefit (provision) by applying an estimate of the annual effective tax rate to the year-to-date pretax book income (loss) and adjusting for discrete items during the reporting period, if any. Tax jurisdictions with losses for which tax benefits cannot be realized, as well as significant unusual or infrequently occurring items that are separately reported, are excluded from the annual effective tax rate. Our tax rate for the three months ended March 31, 2023 of 1%, differed from the federal statutory rate of 21% due to the impact of valuation allowances on deferred tax assets, the forecasted mix of earnings in domestic and international jurisdictions, U.S. taxation of foreign earnings including GILTI (Global Intangible Low Taxed Income) tax, net of Section 250 deduction (largely driven by research and development capitalization), Subpart F income, an expense related to stock-based compensation, tax credits, and uncertain tax positions. Our tax rate for the three months ended March 31, 2022 of 81%, differed from the federal statutory rate of 21% due to losses in jurisdictions for which no benefit is recognized because of valuation allowances on deferred tax assets, the forecasted mix of earnings in domestic and international jurisdictions, GILTI tax, net of Section 250 deduction (largely driven by research and development capitalization), discrete tax expense related to the Dresser Utility Solutions (Dresser) divestiture, an expense related to stock-based compensation, and uncertain tax positions. Beginning January 1, 2022, the Tax Cuts and Jobs Act of 2017 eliminated the option to deduct research and development expenditures currently and requires taxpayers to capitalize and amortize them over five or fifteen years, dependent upon the geography in which the expenditures are incurred. Although Congress has considered legislation that would defer, modify, or repeal the capitalization and amortization requirement, as of quarter end no such deferral has been passed. The income tax provision has been prepared according to currently enacted tax legislation. In August 2022, the Inflation Reduction Act was signed into law, which made a number of changes to the Internal Revenue Code, including adding a 1% excise tax on stock buybacks by publicly traded corporations and a 15% minimum tax on adjusted financial statement income of certain large companies. We are subject to the new 1% excise tax beginning January 1, 2023, but the amount will vary depending upon various factors. The 15% minimum tax only applies to corporations with average book income in excess of $1 billion, therefore it is not currently applicable. The Organization for Economic Cooperation and Development (OECD) Pillar 2 global minimum tax rules are intended to apply for tax years beginning in 2024. On February 1, 2023, the FASB staff noted that they believe that the Pillar 2 tax would be an alternative minimum tax and therefore deferred tax assets would not need to be recognized related to this parallel taxing system. On February 2, 2023, the OECD issued administrative guidance providing transition and safe harbor rules around the implementation of the Pillar 2 global minimum tax. The Company is closely monitoring developments and evaluating the impacts these new rules will have on our tax rate, including eligibility to qualify for these safe harbor rules. We classify interest expense and penalties related to unrecognized tax liabilities and interest income on tax overpayments as components of income tax expense. The net interest and penalties expense amounts recognized were as follows:
Accrued interest and penalties recognized were as follows:
Unrecognized tax benefits related to uncertain tax positions and the amount of unrecognized tax benefits that, if recognized, would affect our effective tax rate were as follows:
At March 31, 2023, we are under examination by certain tax authorities. During the first quarter 2023, we settled a French tax audit on years 2019-2020 with minimal impact to the financial statements or cash taxes. We believe we have appropriately accrued for the expected outcome of all tax matters and do not currently anticipate that the ultimate resolution of these examinations will have a material adverse effect on our financial condition, future results of operations, or cash flows. Based upon the timing and outcome of examinations, litigation, the impact of legislative, regulatory, and judicial developments, and the impact of these items on the statute of limitations, it is reasonably possible that the related unrecognized tax benefits could change from those recognized within the next 12 months. However, at this time, an estimate of the range of reasonably possible adjustments to the balance of unrecognized tax benefits cannot be made. We file income tax returns in various jurisdictions. The material jurisdictions where we are subject to examination include, among others, the United States, France, Germany, Italy, Indonesia, and the United Kingdom.
|
Commitments and Contingencies |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies | Commitments and Contingencies Guarantees and Indemnifications We are often required to obtain standby letters of credit (LOCs) or bonds in support of our obligations for customer contracts. These standby LOCs or bonds typically provide a guarantee to the customer for our future performance, which usually covers the installation phase of a contract and may, on occasion, cover the operations and maintenance phase of outsourcing contracts. Our available lines of credit, outstanding standby LOCs, and bonds were as follows:
In the event any such standby LOC or bond is called, we would be obligated to reimburse the issuer of the standby LOC or bond; however, as of May 4, 2023, we do not believe any outstanding standby LOCs or bonds will be called. We generally provide an indemnification related to the infringement of any patent, copyright, trademark, or other intellectual property right on software or equipment within our sales contracts, which indemnifies the customer from, and pays the resulting costs, damages, and attorney's fees awarded against a customer with respect to, such a claim provided that (a) the customer promptly notifies us in writing of the claim and (b) we have the sole control of the defense and all related settlement negotiations. We may also provide an indemnification to our customers for third-party claims resulting from damages caused by the negligence or willful misconduct of our employees/agents in connection with the performance of certain contracts. The terms of our indemnifications generally do not limit the maximum potential payments. It is not possible to predict the maximum potential amount of future payments under these or similar agreements.Legal Matters We are subject to various legal proceedings and claims of which the outcomes are subject to significant uncertainty. Our policy is to assess the likelihood of any adverse judgments or outcomes related to legal matters, as well as ranges of probable losses. A determination of the amount of the liability required, if any, for these contingencies is made after an analysis of each known issue. A liability would be recognized and charged to operating expense when we determine that a loss is probable and the amount can be reasonably estimated. Additionally, we disclose contingencies for which a material loss is reasonably possible, but not probable. Warranty A summary of the warranty accrual account activity is as follows:
Total warranty expense is classified within cost of revenues and consists of new product warranties issued, costs related to insurance and supplier recoveries, other changes and adjustments to warranties, and customer claims. Warranty expense was as follows:
|
Restructuring (Notes) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring and Related Activities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring | 2023 Projects On February 23, 2023, our Board of Directors approved a restructuring plan (the 2023 Projects). The 2023 Projects include activities that continue Itron's efforts to optimize its global supply chain and manufacturing operations, sales and marketing organizations, and other overhead. These projects are to be substantially complete by early 2025. The total expected restructuring costs, the restructuring costs recognized, and the remaining expected restructuring costs related to the 2023 Projects were as follows:
2021 Projects On October 29, 2021, our Board of Directors approved a restructuring plan (the 2021 Projects), which in conjunction with the announcement of the sale of certain Gas product lines from our Device Solutions manufacturing and business operations in Europe and North America to Dresser, includes activities to drive reductions in certain locations and functional support areas. These projects are expected to be substantially complete by the end of 2024. The total expected restructuring costs, the restructuring costs recognized, and the remaining expected restructuring costs related to the 2021 Projects were as follows:
2020 Projects In September 2020, our Board of Directors approved a restructuring plan (the 2020 Projects), which includes activities that continue our efforts to optimize our global supply chain and manufacturing operations, sales and marketing organizations, and other overhead. These projects are scheduled to be substantially complete by the end of 2023. The total expected restructuring costs, the restructuring costs recognized, and the remaining expected restructuring costs related to the 2020 Projects were as follows:
The following table summarizes the activity within the restructuring related balance sheet accounts for the 2023 Projects, the 2021 Projects, and the 2020 Projects during the three months ended March 31, 2023:
Asset impairments are determined at the asset group level. Revenues and net operating income from the activities we have exited or will exit under the restructuring projects are not material to our operating segments or consolidated results. Certain of Itron's employees are represented by unions or works councils, which requires consultation, and potential restructuring projects may be subject to regulatory approval, both of which could impact the timing of planned savings in certain jurisdictions. Other restructuring costs include expenses for employee relocation, professional fees associated with employee severance, costs to exit the facilities once the operations in those facilities have ceased, and other costs associated with the liquidation of any affected legal entities. Costs associated with restructuring activities are generally presented in the Consolidated Statements of Operations as restructuring, except for certain costs associated with inventory write-downs, which are classified within cost of revenues, and accelerated depreciation expense, which is recognized according to the use of the asset. Restructuring expense is part of the Corporate unallocated segment and does not impact the results of our operating segments. The current portions of restructuring liabilities were $14.3 million and $14.5 million as of March 31, 2023 and December 31, 2022 and are classified within other current liabilities on the Consolidated Balance Sheets. The long-term portions of restructuring liabilities were $61.4 million and $27.9 million as of March 31, 2023 and December 31, 2022. The long-term portions of restructuring liabilities are classified within other long-term obligations on the Consolidated Balance Sheets and include severance accruals and facility exit costs.
|
Shareholders' Equity |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shareholders' Equity | Preferred Stock We have authorized the issuance of 10 million shares of preferred stock with no par value. In the event of a liquidation, dissolution, or winding up of the affairs of the corporation, whether voluntary or involuntary, the holders of any outstanding preferred stock would be entitled to be paid a preferential amount per share to be determined by the Board of Directors prior to any payment to holders of common stock. There was no preferred stock issued or outstanding at March 31, 2023 or December 31, 2022. Convertible Note Hedge Transactions We paid an aggregate amount of $84.1 million for the convertible note hedge transactions. The convertible note hedge transactions cover, subject to anti-dilution adjustments substantially similar to those in the convertible notes, approximately 3.7 million shares of our common stock, the same number of shares initially underlying the convertible notes, at a strike price of approximately $126.00, subject to customary adjustments. The convertible note hedge transactions will expire upon the maturity of the convertible notes, subject to earlier exercise or termination. The convertible note hedge transactions are expected generally to reduce the potential dilutive effect of the conversion of our convertible notes and/or offset any cash payments we are required to make in excess of the principal amount of the converted notes, as the case may be, in the event that the market price per share of our common stock, as measured under the terms of the convertible note hedge transactions, is greater than the strike price of the convertible note hedge transactions. The convertible note hedge transactions meet the criteria in Accounting Standards Codification (ASC) 815-40 to be classified within Stockholders' Equity, and therefore the convertible note hedge transactions are not revalued after their issuance. We made a tax election to integrate the convertible notes and the call options. We are retaining the identification statements in our books and records, together with a schedule providing the accruals on the synthetic debt instruments. The accounting impact of this tax election makes the call options deductible as original issue discount for tax purposes over the term of the convertible notes, and results in a $20.6 million deferred tax asset recognized through equity. Warrant Transactions In addition, concurrently with entering into the convertible note hedge transactions, we separately entered into privately-negotiated warrant transactions (the warrant transactions), whereby we sold to the Counterparties warrants to acquire, collectively, subject to anti-dilution adjustments, 3.7 million shares of our common stock at an initial strike price of $180.00 per share, which represents a premium of 100% over the public offering price in the common stock issuance. We received aggregate proceeds of $45.3 million from the warrant transactions with the Counterparties, with such proceeds partially offsetting the costs of entering into the convertible note hedge transactions. The warrants expire in June 2026. If the market value per share of our common stock, as measured under the warrant transactions, exceeds the strike price of the warrants, the warrants will have a dilutive effect on our earnings per share, unless we elect, subject to certain conditions, to settle the warrants in cash. The warrants meet the criteria in ASC 815-40 to be classified within Stockholders' Equity, and therefore the warrants are not revalued after issuance. Accumulated Other Comprehensive Income (Loss) (AOCI) The changes in the components of AOCI, net of tax, were as follows:
The before-tax, income tax (provision) benefit, and net-of-tax amounts related to each component of other comprehensive income (OCI) were as follows:
|
Fair Values of Financial Instruments |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Values of Financial Instruments | Fair Value of Financial Instruments The fair values at March 31, 2023 and December 31, 2022 do not reflect subsequent changes in the economy, interest rates, tax rates, and other variables that may affect the determination of fair value.
The following methods and assumptions were used in estimating fair values: Cash and cash equivalents: Due to the liquid nature of these instruments, the carrying amount approximates fair value (Level 1). Credit facility - multicurrency revolving line of credit: The revolver is not traded publicly. The fair values, which are determined based upon a hypothetical market participant, are calculated using a discounted cash flow model with Level 2 inputs, including estimates of incremental borrowing rates for debt with similar terms, maturities, and credit profiles. Refer to Note 6: Debt for a further discussion of our debt. Convertible notes: The convertible notes are not listed on any securities exchange but may be actively traded. The fair value is estimated using Level 1 inputs, as it is based on quoted prices for these instruments in active markets. Derivatives: Each derivative asset and liability has a carrying value equal to fair value. The fair values of our derivative instruments are determined using the income approach and significant other observable inputs (and are classified as "Level 2" in the fair value hierarchy). We have used observable market inputs based on the type of derivative and the nature of the underlying instrument. The key inputs include foreign exchange spot and forward rates, all of which are available in an active market. We have utilized the mid-market pricing convention for these inputs.
|
Segment Information |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Information | We operate under the Itron brand worldwide and manage and report under three operating segments: Device Solutions, Networked Solutions, and Outcomes. We have three GAAP measures of segment performance: revenues, gross profit (gross margin), and operating income (operating margin). Intersegment revenues are minimal. Certain operating expenses are allocated to the operating segments based upon internally established allocation methodologies. Corporate operating expenses, interest income, interest expense, other income (expense), and the income tax provision (benefit) are neither allocated to the segments, nor are they included in the measure of segment performance. Goodwill impairment charges are recognized in Corporate unallocated. In addition, we allocate only certain production assets and intangible assets to our operating segments. We do not manage the performance of the segments on a balance sheet basis. Segment Products Device Solutions – This segment primarily includes hardware products used for measurement, control, or sensing that do not have communications capability embedded for use with our broader Itron systems, i.e., hardware-based products not part of a complete end-to-end solution. Examples from the Device Solutions portfolio include: standard endpoints that are shipped without Itron communications, such as our standard gas, electricity, and water meters for a variety of global markets and adhering to regulations and standards within those markets, as well as our heat and allocation products; communicating meters that are not a part of an Itron end-to-end solution, such as Smart Spec meters; and the implementation and installation of non-communicating devices. Networked Solutions – This segment primarily includes a combination of communicating devices (e.g., smart meters, modules, endpoints, and sensors), network infrastructure, and associated application software designed and sold as a complete solution for acquiring and transporting robust application-specific data. Networked Solutions includes products and software for the implementation, installation, and management of communicating devices and data networks. The Industrial Internet of Things (IIoT) solutions supported by this segment include automated meter reading (AMR), advanced metering infrastructure (AMI), distributed energy resource management (DERMs), smart grid and distribution automation, smart street lighting, and an ever-growing set of smart city applications such as traffic management, smart parking, air quality monitoring, electric vehicle charging, customer engagement, digital signage, acoustic (e.g., gunshot) detection, and leak detection and mitigation for both gas and water systems. Our IIoT platform allows all these utility and smart city applications to be run and managed on a single, multi-purpose network. Outcomes – This segment primarily includes our value-added, enhanced software and services in which we manage, organize, analyze, and interpret raw, anonymized and aggregated data to improve decision making, maximize operational profitability, drive resource efficiency, improve grid analytics, and deliver results for consumers, utilities, and smart cities. Outcomes supports high-value use cases such as data management, grid operations, distributed intelligence, operations management, gas distribution and safety, water operations management, revenue assurance, DERMs, energy forecasting, consumer engagement, smart payment, and fleet energy resource management. Utilities leverage these outcomes to capitalize on the power of networks and devices, empower their workforce, maximize their operations, and enhance the customer experience. The revenues from these offerings are primarily recurring in nature and would include any direct management of Device Solutions, Networked Solutions, and other products on behalf of our end customers. Revenues, gross profit, and operating income (loss) associated with our operating segments were as follows:
For the three months ended March 31, 2023 and 2022, no single customer represented more than 10% of total company revenue. Revenues by region were as follows:
Depreciation expense is allocated to the operating segments based upon each segment's use of the assets. All amortization expense is recognized within Corporate unallocated. Depreciation and amortization of intangible assets expense associated with our operating segments was as follows:
|
Revenue Recognition |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenues [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenue Recognition | A summary of significant net changes in the contract assets and the contract liabilities balances during the period is as follows:
On January 1, 2023, total contract assets were $57.0 million and total contract liabilities were $133.0 million. On March 31, 2023, total contract assets were $61.3 million and total contract liabilities were $168.5 million. The contract assets primarily relate to contracts that include a retention clause and allocations related to contracts with multiple performance obligations. The contract liabilities primarily relate to deferred revenue, such as extended warranty and maintenance cost. The cumulative catch-up adjustments relate to contract modifications, measure-of-progress changes, and changes in the estimate of the transaction price. Transaction price allocated to the remaining performance obligations Total transaction price allocated to remaining performance obligations represents committed but undelivered products and services for contracts and purchase orders at period end. Twelve-month remaining performance obligations represent the portion of total transaction price allocated to remaining performance obligations that we estimate will be recognized as revenue over the next 12 months. Total transaction price allocated to remaining performance obligations is not a complete measure of our future revenues as we also receive orders where the customer may have legal termination rights but are not likely to terminate. Total transaction price allocated to remaining performance obligations related to contracts is approximately $1.7 billion for the next 12 months and approximately $1.8 billion for periods longer than 12 months. The total remaining performance obligations consist of product and service components. The service component relates primarily to maintenance agreements for which customers pay a full year's maintenance in advance, and service revenues are generally recognized over the service period. Total transaction price allocated to remaining performance obligations also includes our extended warranty contracts, for which revenue is recognized over the warranty period, and hardware, which is recognized as units are delivered. The estimate of when remaining performance obligations will be recognized requires significant judgment. Cost to obtain a contract and cost to fulfill a contract with a customer Cost to obtain a contract and costs to fulfill a contract were capitalized and amortized using a systematic rational approach to align with the transfer of control of underlying contracts with customers. While amounts were capitalized, they are not material. Disaggregation of revenue Refer to Note 15: Segment Information and the Consolidated Statements of Operations for disclosure regarding the disaggregation of revenue into categories, which depict how revenue and cash flows are affected by economic factors. Specifically, our operating segments and geographical regions as disclosed, and categories for products, which include hardware and software and services, are presented.
|
Summary of Significant Accounting Policies (Policies) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Basis of Presentation | Financial Statement Preparation The consolidated financial statements presented in this Quarterly Report on Form 10-Q are unaudited and reflect entries necessary for the fair presentation of the Consolidated Statements of Operations and the Consolidated Statements of Comprehensive Income (Loss) for the three months ended March 31, 2023 and 2022, Consolidated Statements of Equity for the three months ended March 31, 2023 and 2022, the Consolidated Statements of Cash Flows for the three months ended March 31, 2023 and 2022, and the Consolidated Balance Sheets as of March 31, 2023 and December 31, 2022, of Itron, Inc. and its subsidiaries. All entries required for the fair presentation of the financial statements are of a normal recurring nature, except as disclosed. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results expected for the full year or for any other period. Certain information and notes normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (GAAP) have been partially or completely omitted pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC) regarding interim results. These consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto for the fiscal year ended December 31, 2022 filed with the SEC in our Annual Report on Form 10-K on February 27, 2023 (2022 Annual Report). There have been no significant changes in financial statement preparation or significant accounting policies since December 31, 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
New Accounting Pronouncements | Reclassification In the Consolidated Statements of Cash Flows, the following reclassifications have been made to prior year amounts to conform to current year presentation of restructuring liabilities:
Recently Adopted Accounting Standards In October 2021, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2021-08 amending Business Combination: (Topic 805), which was necessary due to 2014-09, Revenue from Contracts with Customers (Topic 606). The FASB issued this Update to improve the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to (1) recognition of an acquired contract liability and (2) payment terms and their effect on subsequent revenue recognized by the acquirer. We adopted this amendment as of the effective date of January 1, 2023. These amendments are to be applied prospectively to business combinations occurring on or after the effective date of the amendments. We currently plan to apply the practical expedients as needed for any future acquisitions. The practical expedients cover contracts that were modified prior to acquisition date as well as determining which date an acquirer would have to determine the standalone selling price of each performance obligation in an acquired contract.
|
Earnings Per Share (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Computation of Basic and Diluted Earnings Per Share | The following table sets forth the computation of basic and diluted earnings per share (EPS):
|
Certain Balance Sheet Components (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance Sheet Related Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounts Receivable, Net | A summary of accounts receivable from contracts with customers is as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allowance for Credit Losses on Financing Receivables |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inventories |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Property, Plant, and Equipment, Net |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Depreciation Expense |
|
Intangible Assets and Liabilities (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Intangible Assets, Net (Excluding Goodwill) [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Intangible Assets by Major Class | The gross carrying amount and accumulated amortization (accretion) of our intangible assets and liabilities, other than goodwill, were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Intangible Asset Account Activity | A summary of intangible assets and liabilities activity is as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Intangible Assets, Future Amortization Expense | Estimated future annual amortization is as follows:
|
Goodwill (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill Excluding Non Goodwill Intangibles [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Goodwill | The following table reflects changes in the carrying amount of goodwill for the three months ended March 31, 2023:
|
Debt (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Debt | The components of our borrowings were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Maturities of Long-term Debt | The amount of required minimum principal payments on our long-term debt in aggregate over the next five years is as follows:
|
Defined Benefit Pension Plans (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Retirement Benefits [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Amounts Recognized in the Consolidated Balance Sheets | Amounts recognized on the Consolidated Balance Sheets consist of:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Net Periodic Pension Benefit Costs | Net periodic pension benefit cost for our plans includes the following components:
|
Stock-Based Compensation (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-Based Payment Arrangement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock-Based Compensation Expense and Related Tax Benefit | Total stock-based compensation expense and the related tax benefit were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Employee Stock Options Activity | A summary of our stock option activity is as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restricted Stock Units Award Activity | The following table summarizes restricted stock unit activity:
(1) Shares released is presented as gross shares and does not reflect shares withheld by us for employee payroll tax obligations.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restricted Stock Units, Valuation Assumptions | The weighted average assumptions used to estimate the fair value of performance-based restricted stock units granted with a service and market condition and the resulting weighted average fair value are as follows:
|
Income Taxes (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Tax Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unrecognized Tax Benefits Related To Uncertain Tax Positions | The net interest and penalties expense amounts recognized were as follows:
Accrued interest and penalties recognized were as follows:
Unrecognized tax benefits related to uncertain tax positions and the amount of unrecognized tax benefits that, if recognized, would affect our effective tax rate were as follows:
|
Commitments and Contingencies (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Line of Credit Facilities | Our available lines of credit, outstanding standby LOCs, and bonds were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Warranty Accruals | A summary of the warranty accrual account activity is as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warranty Expense | Warranty expense was as follows:
|
Restructuring (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring and Related Activities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Restructuring Reserve by Type of Cost | The total expected restructuring costs, the restructuring costs recognized, and the remaining expected restructuring costs related to the 2023 Projects were as follows:
The total expected restructuring costs, the restructuring costs recognized, and the remaining expected restructuring costs related to the 2021 Projects were as follows:
The total expected restructuring costs, the restructuring costs recognized, and the remaining expected restructuring costs related to the 2020 Projects were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring and Related Costs | The following table summarizes the activity within the restructuring related balance sheet accounts for the 2023 Projects, the 2021 Projects, and the 2020 Projects during the three months ended March 31, 2023:
|
Shareholders' Equity (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Accumulated Other Comprehensive Income (Loss) | The changes in the components of AOCI, net of tax, were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total Comprehensive Income (Loss) | The before-tax, income tax (provision) benefit, and net-of-tax amounts related to each component of other comprehensive income (OCI) were as follows:
|
Fair Values of Financial Instruments (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Fair Values Of Financial Instruments by Balance Sheet Grouping | The fair values at March 31, 2023 and December 31, 2022 do not reflect subsequent changes in the economy, interest rates, tax rates, and other variables that may affect the determination of fair value.
|
Segment Information (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenues Gross Profit And Operating Income By Segment | Revenues, gross profit, and operating income (loss) associated with our operating segments were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenues By Region | Revenues by region were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Depreciation And Amortization Expense Associated With Segments | Depreciation and amortization of intangible assets expense associated with our operating segments was as follows:
|
Revenue Recognition (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenues [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contract with Customer, Asset and Liability | A summary of significant net changes in the contract assets and the contract liabilities balances during the period is as follows:
|
Summary of Significant Accounting Policies (Details) |
3 Months Ended |
---|---|
Mar. 31, 2023 | |
Accounting Policies [Abstract] | |
Risks and uncertainties in entity's business | Risks and UncertaintiesThe pandemic has resulted in global economic impacts including disrupting customer demand and global supply chains, resulting in market volatility, which our management continues to monitor. As economies have reopened, global supply chains have struggled to keep pace with rapidly changing demand. The resulting supply constraints have manifested across a variety of areas including mechanical, electrical, and logistics portions of the supply chain, which has impacted our ability to ship products in a timely manner. In particular, our ability to obtain adequate supply of semiconductor components has impacted our ability to service recovering customer demand. While we believe the current imbalance in supply and demand is temporal, the timeline to recovery is uncertain. Efforts are ongoing with suppliers to increase supply, including the approval of alternate sources. Recently, inflation in our raw materials and component costs, freight charges, and labor costs have increased above historical levels, due to, among other things, the continuing impacts of the uncertain economic environment. We may or may not be able to fully recover these increased costs through pricing actions with our customers. At this time, we have not identified any significant decrease in long-term customer demand for our products and services. However, certain of our customer projects have experienced delay in deliveries, with revenues originally forecasted in prior periods shifting to future periods.While we have limited direct business exposure in Russia, Belarus and Ukraine, the Russian military actions and the resulting sanctions could adversely affect the global economy, as well as further disrupt the supply chain. A major disruption in the global economy and supply chain could have a material adverse effect on our business, prospects, financial condition, results of operations, and cash flows. The extent and duration of the military action, sanctions, and resulting market and/or supply disruptions are impossible to predict, but could be substantial, and our management continues to monitor these events closely. |
Summary of Significant Accounting Policies - Reclassification (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2023 |
Mar. 31, 2022 |
|
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||
Accounts payable, other current liabilities, and taxes payable | $ 15,113 | $ 17,778 |
Restructuring | 33,209 | (13,167) |
Other operating, net | $ (7,091) | (2,478) |
Previously Reported | ||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||
Accounts payable, other current liabilities, and taxes payable | 14,065 | |
Restructuring | 0 | |
Other operating, net | (11,932) | |
Revision of Prior Period, Adjustment | ||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||
Accounts payable, other current liabilities, and taxes payable | 3,713 | |
Restructuring | (13,167) | |
Other operating, net | $ 9,454 |
Earnings Per Share - Computation of Basic and Diluted Earnings per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2023 |
Mar. 31, 2022 |
|
Earnings Per Share [Abstract] | ||
Net income (loss) available to common shareholders | $ (11,836) | $ 906 |
Weighted average common shares outstanding - Basic (in shares) | 45,281 | 45,018 |
Dilutive effect of stock-based awards (in shares) | 0 | 222 |
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities | 0 | 0 |
Weighted average common shares outstanding - Diluted (in shares) | 45,281 | 45,240 |
Earnings (loss) per common share - Basic (in dollars per share) | $ (0.26) | $ 0.02 |
Earnings (loss) per common share - Diluted (in dollars per share) | $ (0.26) | $ 0.02 |
Earnings Per Share - Stock-based Awards (Details) - shares shares in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2023 |
Mar. 31, 2022 |
|
Earnings Per Share [Abstract] | ||
Stock-based awards excluded from diluted EPS calculation (antidilutive) (in shares) | 0.7 | 0.4 |
Earnings Per Share - Convertible Senior Notes and Warrants (Details) - $ / shares shares in Millions |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2023 |
Mar. 31, 2022 |
Dec. 31, 2021 |
|
Debt Instrument [Line Items] | |||
Treasury stock, shares, acquired | 3.7 | ||
Class of warrant or right, exercise price of warrants or rights | $ 180.00 | ||
Stock-based awards excluded from diluted EPS calculation (antidilutive) (in shares) | 0.7 | 0.4 | |
Convertible Debt Securities [Member] | |||
Debt Instrument [Line Items] | |||
Common stock, conversion price (in dollars per share) | $ 126.00 | $ 126.00 | |
Stock-based awards excluded from diluted EPS calculation (antidilutive) (in shares) | 3.7 | 3.7 |
Earnings Per Share - Convertible Note Hedge Transactions (Details) - $ / shares shares in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2023 |
Dec. 31, 2021 |
|
Debt Instrument [Line Items] | ||
Treasury stock, shares, acquired | 3.7 | |
Convertible Debt Securities [Member] | ||
Debt Instrument [Line Items] | ||
Common stock, conversion price (in dollars per share) | $ 126.00 | $ 126.00 |
Certain Balance Sheet Components Accounts Receivable, Net (Details) - USD ($) $ in Thousands |
Mar. 31, 2023 |
Dec. 31, 2022 |
---|---|---|
Accounts Receivable, after Allowance for Credit Loss, Current [Abstract] | ||
Trade receivables (net of allowance of $4,782 and $4,863) | $ 259,587 | $ 249,771 |
Unbilled receivables | 45,688 | 30,664 |
Total accounts receivable, net | $ 305,275 | $ 280,435 |
Certain Balance Sheet Components Summary of the Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2023 |
Mar. 31, 2022 |
|
Accounts Receivable, after Allowance for Credit Loss, Current [Abstract] | ||
Beginning balance | $ 4,863 | $ 5,730 |
Provision for (release of) doubtful accounts, net | (91) | (101) |
Accounts recovered (written-off), net | (66) | 78 |
Effect of change in exchange rates | 76 | (109) |
Ending balance | $ 4,782 | $ 5,598 |
Certain Balance Sheet Components Inventories (Details) - USD ($) $ in Thousands |
Mar. 31, 2023 |
Dec. 31, 2022 |
---|---|---|
Inventory, Net [Abstract] | ||
Raw materials | $ 215,203 | $ 182,118 |
Work in process | 9,239 | 8,386 |
Finished goods | 40,680 | 38,197 |
Total inventories | $ 265,122 | $ 228,701 |
Certain Balance Sheet Components Property, Plant, and Equipment, Net (Details) - USD ($) $ in Thousands |
Mar. 31, 2023 |
Dec. 31, 2022 |
---|---|---|
Property, Plant and Equipment, Net [Abstract] | ||
Machinery and equipment | $ 312,339 | $ 306,699 |
Computers and software | 120,498 | 119,670 |
Buildings, furniture, and improvements | 130,957 | 130,301 |
Land | 8,668 | 8,566 |
Construction in progress, including purchased equipment | 18,232 | 19,403 |
Total cost | 590,694 | 584,639 |
Accumulated depreciation | (454,297) | (444,516) |
Property, plant, and equipment, net | $ 136,397 | $ 140,123 |
Certain Balance Sheet Components Depreciation Expense (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2023 |
Mar. 31, 2022 |
|
Property, Plant and Equipment [Abstract] | ||
Depreciation expense | $ 9,415 | $ 10,284 |
Summary of Intangible Asset Account Activity (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2023 |
Mar. 31, 2022 |
|
Total Intangible Assets [Abstract] | ||
Intangible assets, gross beginning balance | $ 905,134 | $ 928,422 |
Effect of change in exchange rates | 4,929 | (5,578) |
Intangible assets, gross ending balance | 910,063 | 922,844 |
Intangible liabilities, gross beginning balance | 23,900 | 23,900 |
Effect of change in exchange rates | 0 | 0 |
Intangible liabilities, gross ending balance | $ 23,900 | $ 23,900 |
Intangible Assets and Liabilities Estimated Future Annual Amortization Expense (Details) $ in Thousands |
Mar. 31, 2023
USD ($)
|
---|---|
Intangible Assets [Abstract] | |
2023 (amount remaining at March 31, 2023) | $ 13,955 |
2024 | 15,080 |
2025 | 14,342 |
2026 | 10,329 |
2027 | 5,630 |
Thereafter | 716 |
Total intangible assets subject to amortization | $ 60,052 |
Schedule of Goodwill Allocated to Reporting Segments (Details) $ in Thousands |
3 Months Ended |
---|---|
Mar. 31, 2023
USD ($)
| |
Goodwill [Roll Forward] | |
Goodwill, net, at beginning of period | $ 1,038,721 |
Effect of change in exchange rates | 5,940 |
Goodwill, Ending Balance | 1,044,661 |
Device Solutions [Member] | |
Goodwill [Roll Forward] | |
Goodwill, net, at beginning of period | 0 |
Effect of change in exchange rates | 0 |
Goodwill, Ending Balance | 0 |
Networked Solutions Segment [Member] | |
Goodwill [Roll Forward] | |
Goodwill, net, at beginning of period | 899,887 |
Effect of change in exchange rates | 5,155 |
Goodwill, Ending Balance | 905,042 |
Outcomes Segment [Member] | |
Goodwill [Roll Forward] | |
Goodwill, net, at beginning of period | 138,834 |
Effect of change in exchange rates | 785 |
Goodwill, Ending Balance | $ 139,619 |
Debt - Schedule of Debt Components of Borrowing (Details) - USD ($) $ in Thousands |
Mar. 31, 2023 |
Dec. 31, 2022 |
---|---|---|
Debt Instrument [Line Items] | ||
Convertible Debt | $ 460,000 | $ 460,000 |
Total debt | 460,000 | |
Long-term debt, net | 453,094 | 452,526 |
Line of Credit [Member] | ||
Debt Instrument [Line Items] | ||
Multicurrency revolving line of credit | 0 | 0 |
Secured Debt [Member] | ||
Debt Instrument [Line Items] | ||
Total debt | 460,000 | 460,000 |
Long-term debt, net | 453,094 | 452,526 |
Convertible Debt Securities [Member] | ||
Debt Instrument [Line Items] | ||
Unamortized prepaid debt fees | $ 6,906 | $ 7,474 |
Debt - Convertible Note Additional Information (Details) $ / shares in Units, $ in Millions |
37 Months Ended | |
---|---|---|
Mar. 12, 2021
USD ($)
$ / shares
|
Jan. 14, 2021 |
|
Maximum [Member] | ||
Debt Instrument [Line Items] | ||
Debt instrument, redemption price, percentage | 98.00% | |
Debt Instrument, Redemption, Period Four [Member] | ||
Debt Instrument [Line Items] | ||
Debt instrument, redemption price, percentage | 130.00% | |
Convertible Debt [Member] | ||
Debt Instrument [Line Items] | ||
Proceeds from convertible debt | $ | $ 448.5 | |
Debt instrument, convertible, conversion ratio | 0.0079365 | |
Debt instrument, convertible, conversion price | $ / shares | $ 126.00 |
Debt - Minimum Required Principal Payments (Details) $ in Thousands |
Mar. 31, 2023
USD ($)
|
---|---|
Text Block [Abstract] | |
2023 (amount remaining at March 31, 2023) | $ 0 |
2024 | 0 |
2025 | 0 |
2026 | 460,000 |
2027 | 0 |
Thereafter | 0 |
Total debt | $ 460,000 |
Derivative Financial Instruments - Narrative (Details) |
Mar. 31, 2023
USD ($)
contracts
|
Dec. 31, 2021
USD ($)
|
---|---|---|
Derivative Instruments, Gain (Loss) [Line Items] | ||
Derivative, notional amount | $ 84,100,000 | |
Forward Contracts [Member] | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Number of foreign exchange contracts | contracts | 38 | |
Foreign Exchange Contract [Member] | Minimum [Member] | Not Designated as Hedging Instrument [Member] | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Derivative, notional amount | $ 115,000 | |
Foreign Exchange Contract [Member] | Maximum [Member] | Not Designated as Hedging Instrument [Member] | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Derivative, notional amount | $ 47,000,000 |
Schedule of Amounts Recognized in the Consolidated Balance Sheets (Details) - USD ($) $ in Thousands |
Mar. 31, 2023 |
Dec. 31, 2022 |
---|---|---|
Retirement Benefits [Abstract] | ||
Plan assets in other long-term assets | $ 167 | $ 162 |
Current portion of pension benefit obligation in wages and benefits payable | 3,562 | 3,400 |
Long-term portion of pension benefit obligation | 59,127 | 57,839 |
Pension benefit obligation, net | $ 62,522 | $ 61,077 |
Schedule of Net Periodic Pension Benefit Costs (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2023 |
Mar. 31, 2022 |
|
Retirement Benefits [Abstract] | ||
Service cost | $ 604 | $ 794 |
Interest cost | 712 | 443 |
Expected return on plan assets | (87) | (83) |
Amortization of prior service costs | 15 | 18 |
Amortization of actuarial net loss | (121) | 235 |
Net periodic benefit cost | $ 1,123 | $ 1,407 |
Stock-Based Compensation - Expense and Related Tax Benefit (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2023 |
Mar. 31, 2022 |
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Stock options | $ 60 | $ 284 |
Restricted stock units | 6,583 | 5,584 |
Unrestricted stock awards | 276 | 259 |
Total stock-based compensation | 7,696 | 6,317 |
Related tax benefit | 1,703 | 1,369 |
Phantom Share Units (PSUs) [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Phantom stock units | $ 777 | $ 190 |
Stock-Based Compensation - Long-Term Performance Restricted Stock Unit Award Monte Carlo Pricing Model Assumptions (Details) - Restricted Stock Units (RSUs) [Member] - $ / shares |
3 Months Ended | |
---|---|---|
Mar. 31, 2023 |
Mar. 31, 2022 |
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Granted, weighted average grant date fair value (in dollars per share) | $ 55.59 | $ 53.95 |
Long Term Performance Restricted Stock Award [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Expected volatility | 50.00% | 55.70% |
Risk-free interest rate | 4.60% | 1.70% |
Expected term (years) | 2 years 2 months 12 days | 2 years 10 months 24 days |
Granted, weighted average grant date fair value (in dollars per share) | $ 59.22 | $ 57.88 |
Income Taxes - Contingencies (Details) - USD ($) $ in Thousands |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2023 |
Mar. 31, 2022 |
Dec. 31, 2022 |
|
Income Tax Disclosure [Abstract] | |||
Net interest and penalties expense | $ 250 | $ 170 | |
Accrued interest | 8,054 | $ 7,575 | |
Accrued penalties | 465 | 567 | |
Unrecognized tax benefits related to uncertain tax positions | 124,923 | 130,144 | |
The amount of unrecognized tax benefits that, if recognized, would affect our effective tax rate | $ 124,915 | $ 130,137 |
Income Taxes - Narrative (Details) |
3 Months Ended | |
---|---|---|
Mar. 31, 2023 |
Mar. 31, 2022 |
|
Income Tax Examination [Line Items] | ||
Effective income tax rate reconciliation, percent | 1.00% | 81.00% |
Effective income tax rate reconciliation, at federal statutory income tax rate, percent | 21.00% | 21.00% |
Commitments and Contingencies - Available Lines of Credit, Outstanding Standby Letter of Credits, and Bonds (Details) - USD ($) $ in Thousands |
Mar. 31, 2023 |
Dec. 31, 2022 |
Oct. 18, 2019 |
---|---|---|---|
Line of Credit Facility [Line Items] | |||
Multicurrency revolving line of credit | $ 500,000 | ||
Net available for additional standby LOCs under sub-facility | $ 237,942 | $ 244,010 | |
Credit Facility [Member] | |||
Line of Credit Facility [Line Items] | |||
Multicurrency revolving line of credit | 500,000 | 500,000 | |
Letters of Credit Outstanding, Amount | (62,058) | (55,990) | |
Line of Credit Facility, Remaining Borrowing Capacity | 237,900 | ||
Unsecured Multicurrency Revolving Lines of Credit [Member] | |||
Line of Credit Facility [Line Items] | |||
Multicurrency revolving line of credit | 83,732 | 81,781 | |
Letters of Credit Outstanding, Amount | (22,742) | (22,530) | |
Short-term borrowings | 0 | 0 | |
Line of Credit Facility, Remaining Borrowing Capacity | 60,990 | 59,251 | |
Surety Bond [Member] | |||
Line of Credit Facility [Line Items] | |||
Unsecured surety bonds in force | 271,202 | 285,754 | |
Line of Credit [Member] | |||
Line of Credit Facility [Line Items] | |||
Long-term Line of Credit | 0 | 0 | |
Line of Credit Facility, Remaining Borrowing Capacity | $ 437,942 | $ 444,010 |
Commitments and Contingencies - Warranty Account Activity (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2023 |
Mar. 31, 2022 |
|
Commitments and Contingencies Disclosure [Abstract] | ||
Beginning balance | $ 25,698 | $ 32,022 |
New product warranties | 1,630 | 1,466 |
Other changes/adjustments to warranties | (689) | 42 |
Claims activity | (1,987) | (2,434) |
Effect of change in exchange rates | 179 | (261) |
Ending balance | 24,831 | 30,835 |
Less: current portion of warranty | 17,829 | 17,651 |
Long-term warranty | $ 7,002 | $ 13,184 |
Commitments and Contingencies - Warranty Expense (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2023 |
Mar. 31, 2022 |
|
Commitments and Contingencies Disclosure [Abstract] | ||
Total warranty expense | $ 941 | $ 1,508 |
Restructuring Expected Costs - Restructuring Reserve by Type of Cost (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2023 |
Dec. 31, 2022 |
|
Restructuring Cost and Reserve [Line Items] | ||
Restructuring | $ 36,609 | |
2023 Projects | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and related cost, expected cost | 44,195 | |
Restructuring and Related Cost, Cost Incurred to Date | $ 0 | |
Restructuring | 38,013 | |
Restructuring and Related Cost, Expected Cost Remaining | 6,182 | |
2021 Projects | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and related cost, expected cost | 51,711 | |
Restructuring and Related Cost, Cost Incurred to Date | 50,042 | |
Restructuring | (731) | |
Restructuring and Related Cost, Expected Cost Remaining | 2,400 | |
2020 Projects | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and related cost, expected cost | 33,990 | |
Restructuring and Related Cost, Cost Incurred to Date | 34,188 | |
Restructuring | (673) | |
Restructuring and Related Cost, Expected Cost Remaining | 475 | |
Employee Severance [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring | 35,066 | |
Employee Severance [Member] | 2023 Projects | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and related cost, expected cost | 36,625 | |
Restructuring and Related Cost, Cost Incurred to Date | 0 | |
Restructuring | 36,625 | |
Restructuring and Related Cost, Expected Cost Remaining | 0 | |
Employee Severance [Member] | 2021 Projects | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and related cost, expected cost | 37,639 | |
Restructuring and Related Cost, Cost Incurred to Date | 38,359 | |
Restructuring | (720) | |
Restructuring and Related Cost, Expected Cost Remaining | 0 | |
Employee Severance [Member] | 2020 Projects | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and related cost, expected cost | 19,543 | |
Restructuring and Related Cost, Cost Incurred to Date | 20,382 | |
Restructuring | (839) | |
Restructuring and Related Cost, Expected Cost Remaining | 0 | |
Asset Impairment and Net (Gain) Loss on Sale or Disposal [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring | 1,070 | |
Asset Impairment and Net (Gain) Loss on Sale or Disposal [Member] | 2023 Projects | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and related cost, expected cost | 1,067 | |
Restructuring and Related Cost, Cost Incurred to Date | 0 | |
Restructuring | 1,067 | |
Restructuring and Related Cost, Expected Cost Remaining | 0 | |
Asset Impairment and Net (Gain) Loss on Sale or Disposal [Member] | 2021 Projects | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and related cost, expected cost | 8,602 | |
Restructuring and Related Cost, Cost Incurred to Date | 8,599 | |
Restructuring | 3 | |
Restructuring and Related Cost, Expected Cost Remaining | 0 | |
Asset Impairment and Net (Gain) Loss on Sale or Disposal [Member] | 2020 Projects | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and related cost, expected cost | 6,465 | |
Restructuring and Related Cost, Cost Incurred to Date | 6,465 | |
Restructuring | 0 | |
Restructuring and Related Cost, Expected Cost Remaining | 0 | |
Other Restructuring [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring | 473 | |
Other Restructuring [Member] | 2023 Projects | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and related cost, expected cost | 6,503 | |
Restructuring and Related Cost, Cost Incurred to Date | 0 | |
Restructuring | 321 | |
Restructuring and Related Cost, Expected Cost Remaining | 6,182 | |
Other Restructuring [Member] | 2021 Projects | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and related cost, expected cost | 5,470 | |
Restructuring and Related Cost, Cost Incurred to Date | 3,084 | |
Restructuring | (14) | |
Restructuring and Related Cost, Expected Cost Remaining | 2,400 | |
Other Restructuring [Member] | 2020 Projects | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and related cost, expected cost | 7,982 | |
Restructuring and Related Cost, Cost Incurred to Date | $ 7,341 | |
Restructuring | 166 | |
Restructuring and Related Cost, Expected Cost Remaining | $ 475 |
Restructuring Additional Information (Details) - USD ($) $ in Millions |
Mar. 31, 2023 |
Dec. 31, 2022 |
---|---|---|
Restructuring Cost and Reserve [Line Items] | ||
Restructuring reserve, current | $ 14.3 | $ 14.5 |
Restructuring reserve, noncurrent | $ 61.4 | $ 27.9 |
Restructuring Related Balance Sheet Activity (Details) $ in Thousands |
3 Months Ended |
---|---|
Mar. 31, 2023
USD ($)
| |
Restructuring Cost and Reserve [Line Items] | |
Beginning balance, January 1, 2023 | $ 42,444 |
Costs charged to expense | 36,609 |
Cash payments | (3,112) |
Net assets disposed and impaired | (1,055) |
Effect of change in exchange rates | 812 |
Ending balance, March 31, 2023 | 75,698 |
Accrued Employee Severance [Member] | |
Restructuring Cost and Reserve [Line Items] | |
Beginning balance, January 1, 2023 | 39,558 |
Costs charged to expense | 35,066 |
Cash payments | (2,899) |
Net assets disposed and impaired | 0 |
Effect of change in exchange rates | 797 |
Ending balance, March 31, 2023 | 72,522 |
Asset Impairment and Net (Gain) Loss on Sale or Disposal [Member] | |
Restructuring Cost and Reserve [Line Items] | |
Beginning balance, January 1, 2023 | 0 |
Costs charged to expense | 1,070 |
Cash payments | (15) |
Net assets disposed and impaired | (1,055) |
Effect of change in exchange rates | 0 |
Ending balance, March 31, 2023 | 0 |
Other Accrued Costs [Member] | |
Restructuring Cost and Reserve [Line Items] | |
Beginning balance, January 1, 2023 | 2,886 |
Costs charged to expense | 473 |
Cash payments | (198) |
Net assets disposed and impaired | 0 |
Effect of change in exchange rates | 15 |
Ending balance, March 31, 2023 | $ 3,176 |
Shareholders' Equity Narrative (Details) $ / shares in Units, $ in Millions |
3 Months Ended | |||
---|---|---|---|---|
Mar. 31, 2023
$ / shares
shares
|
Mar. 31, 2022
shares
|
Dec. 31, 2021
USD ($)
$ / shares
shares
|
Dec. 31, 2022
$ / shares
shares
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Preferred stock, shares authorized (in share) | 10,000,000 | 10,000,000 | ||
Preferred stock, no par value (in dollars per share) | $ / shares | $ 0 | $ 0 | ||
Preferred stock, shares issued (in shares) | 0 | 0 | ||
Preferred stock, shares outstanding (in shares) | 0 | 0 | ||
Derivative, notional amount | $ | $ 84.1 | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 700,000 | 400,000 | ||
Deferred tax assets, derivative instruments | $ | $ 20.6 | |||
Treasury stock, shares, acquired | 3,700,000 | |||
Class of warrant or right, exercise price of warrants or rights | $ / shares | $ 180.00 | |||
Class of Warrant or Right, Premium, Percentage | 1 | |||
Class of Warrant or Right, Aggregate Proceeds From Transaction | $ | $ 45.3 | |||
Convertible Debt Securities [Member] | ||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 3,700,000 | 3,700,000 | ||
Common stock, conversion price (in dollars per share) | $ / shares | $ 126.00 | $ 126.00 |
Shareholders' Equity Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2023 |
Mar. 31, 2022 |
|
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | ||
Beginning balance | $ 1,191,556 | $ 1,142,759 |
Total other comprehensive income (loss), net of tax | 7,119 | 52,815 |
Ending balance | 1,194,143 | 1,186,752 |
Parent [Member] | ||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | ||
Beginning balance | 1,168,473 | 1,116,077 |
Total other comprehensive income (loss), net of tax | 7,119 | 52,815 |
Ending balance | 1,171,282 | 1,160,080 |
Foreign Currency Translation Adjustments | ||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | ||
Beginning balance | (83,193) | (111,766) |
OCI before reclassifications | 7,225 | (6,891) |
Amounts reclassified from AOCI | 0 | 55,436 |
Total other comprehensive income (loss), net of tax | 7,225 | 48,545 |
Ending balance | (75,968) | (63,221) |
Net Unrealized Gain (Loss) on Derivative Instruments | ||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | ||
Beginning balance | (210) | (210) |
OCI before reclassifications | 0 | 0 |
Amounts reclassified from AOCI | 0 | 0 |
Total other comprehensive income (loss), net of tax | 0 | 0 |
Ending balance | (210) | (210) |
Net Unrealized Gain (Loss) on Nonderivative Instruments | ||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | ||
Beginning balance | (14,380) | (14,380) |
OCI before reclassifications | 0 | 0 |
Amounts reclassified from AOCI | 0 | 0 |
Total other comprehensive income (loss), net of tax | 0 | 0 |
Ending balance | (14,380) | (14,380) |
Pension Benefit Obligation Adjustments | ||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | ||
Beginning balance | 3,109 | (21,742) |
OCI before reclassifications | 0 | 4,196 |
Amounts reclassified from AOCI | (106) | 74 |
Total other comprehensive income (loss), net of tax | (106) | 4,270 |
Ending balance | 3,003 | (17,472) |
Accumulated Other Comprehensive Income (Loss) | ||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | ||
Beginning balance | (94,674) | (148,098) |
OCI before reclassifications | 7,225 | (2,695) |
Amounts reclassified from AOCI | (106) | 55,510 |
Total other comprehensive income (loss), net of tax | 7,119 | 52,815 |
Ending balance | $ (87,555) | $ (95,283) |
Shareholders' Equity Other Comprehensive Income (Loss) (Details) - USD ($) |
3 Months Ended | |
---|---|---|
Mar. 31, 2023 |
Mar. 31, 2022 |
|
Before-tax amount [Abstract] | ||
Foreign currency translation adjustment | $ 7,227,000 | $ (6,850,000) |
Foreign currency translation adjustment reclassified to net income (loss) on sale of business | 0 | 55,436,000 |
Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment and Tax | 0 | 4,205,000 |
Net defined benefit plan (gain) loss reclassified to net income (loss) | (106,000) | 74,000 |
Total other comprehensive income (loss), before tax | 7,121,000 | 52,865,000 |
Tax (provision) benefit [Abstract] | ||
Foreign currency translation adjustment | (2,000) | (41,000) |
Foreign currency translation adjustment reclassified to net income (loss) on sale of business | 0 | 0 |
Net unrealized gain (loss) on defined benefit plans | 0 | (9,000) |
Net defined benefit plan (gain) loss reclassified to net income (loss) | 0 | 0 |
Total other comprehensive income (loss) tax (provision) benefit | (2,000) | (50,000) |
Net-of-tax amount [Abstract] | ||
Foreign currency translation adjustment | 7,225,000 | (6,891,000) |
Foreign currency translation adjustment reclassified to net income (loss) on sale of business | 0 | 55,436,000 |
Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax | 0 | 4,196,000 |
Net defined benefit plan (gain) loss reclassified to net income (loss) | (106,000) | 74,000 |
Total other comprehensive income (loss), net of tax | $ 7,119,000 | $ 52,815,000 |
Schedule of Fair Values of Financial Instruments (Details) - USD ($) $ in Thousands |
Mar. 31, 2023 |
Dec. 31, 2022 |
---|---|---|
Line of Credit [Member] | ||
Liabilities | ||
Multicurrency revolving line of credit | $ 0 | $ 0 |
Reported Value Measurement [Member] | ||
Liabilities | ||
Convertible Notes Payable | 453,094 | 452,526 |
Reported Value Measurement [Member] | Line of Credit [Member] | ||
Liabilities | ||
Multicurrency revolving line of credit | 0 | 0 |
Estimate of Fair Value Measurement [Member] | ||
Liabilities | ||
Convertible Notes Payable | 381,621 | 377,200 |
Estimate of Fair Value Measurement [Member] | Line of Credit [Member] | ||
Liabilities | ||
Multicurrency revolving line of credit, fair value | $ 0 | $ 0 |
Segment Information Narrative (Details) |
3 Months Ended |
---|---|
Mar. 31, 2023 | |
Segment Reporting [Abstract] | |
Number of reportable segments | 3 |
Information By Segment (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2023 |
Mar. 31, 2022 |
|
Segment Reporting Information [Line Items] | ||
Revenues | $ 494,618 | $ 475,331 |
Gross profit | 156,368 | 135,224 |
Operating income (loss) | (10,393) | 6,819 |
Total other income (expense) | (1,714) | (2,064) |
Income (loss) before income taxes | (12,107) | 4,755 |
Device Solutions [Member] | ||
Segment Reporting Information [Line Items] | ||
Revenues | 118,254 | 139,565 |
Gross profit | 23,713 | 21,806 |
Operating income (loss) | 14,078 | 11,578 |
Networked Solutions Segment [Member] | ||
Segment Reporting Information [Line Items] | ||
Revenues | 313,468 | 278,820 |
Gross profit | 105,776 | 91,351 |
Operating income (loss) | 74,956 | 61,007 |
Outcomes Segment [Member] | ||
Segment Reporting Information [Line Items] | ||
Revenues | 62,896 | 56,946 |
Gross profit | 26,879 | 22,067 |
Operating income (loss) | 12,911 | 8,341 |
Corporate Unallocated [Member] | ||
Segment Reporting Information [Line Items] | ||
Operating income (loss) | (112,338) | (74,107) |
Product [Member] | ||
Segment Reporting Information [Line Items] | ||
Revenues | 416,324 | 399,810 |
Product [Member] | Device Solutions [Member] | ||
Segment Reporting Information [Line Items] | ||
Revenues | 117,451 | 137,886 |
Product [Member] | Networked Solutions Segment [Member] | ||
Segment Reporting Information [Line Items] | ||
Revenues | 281,470 | 249,268 |
Product [Member] | Outcomes Segment [Member] | ||
Segment Reporting Information [Line Items] | ||
Revenues | 17,403 | 12,656 |
Service [Member] | ||
Segment Reporting Information [Line Items] | ||
Revenues | 78,294 | 75,521 |
Service [Member] | Device Solutions [Member] | ||
Segment Reporting Information [Line Items] | ||
Revenues | 803 | 1,679 |
Service [Member] | Networked Solutions Segment [Member] | ||
Segment Reporting Information [Line Items] | ||
Revenues | 31,998 | 29,552 |
Service [Member] | Outcomes Segment [Member] | ||
Segment Reporting Information [Line Items] | ||
Revenues | $ 45,493 | $ 44,290 |
Segment Information Revenues By Region (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2023 |
Mar. 31, 2022 |
|
Revenues from External Customers [Line Items] | ||
Revenues | $ 494,618 | $ 475,331 |
United States and Canada [Member] | ||
Revenues from External Customers [Line Items] | ||
Revenues | 372,842 | 317,893 |
Europe, Middle East, and Africa [Member] | ||
Revenues from External Customers [Line Items] | ||
Revenues | 98,744 | 129,306 |
Other [Member] | ||
Revenues from External Customers [Line Items] | ||
Revenues | $ 23,032 | $ 28,132 |
Depreciation and Amortization, by Segment (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2023 |
Mar. 31, 2022 |
|
Property, Plant and Equipment [Line Items] | ||
Depreciation and amortization of intangible assets | $ 14,463 | $ 16,837 |
Corporate, Non-Segment [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Depreciation and amortization of intangible assets | 5,816 | 7,554 |
Device Solutions [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Depreciation and amortization of intangible assets | 3,262 | 3,934 |
Networked Solutions Segment [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Depreciation and amortization of intangible assets | 4,131 | 4,440 |
Outcomes Segment [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Depreciation and amortization of intangible assets | $ 1,254 | $ 909 |
Revenue Recognition Revenue Contract Assets and Liabilities Rollforward (Details) $ in Thousands |
3 Months Ended |
---|---|
Mar. 31, 2023
USD ($)
| |
Revenue Recognition and Deferred Revenue [Abstract] | |
Beginning balance, January 1, 2023 | $ 75,958 |
Revenues recognized from beginning contract liability | (52,304) |
Cumulative catch-up adjustments | 3,270 |
Increases due to amounts collected or due | 107,038 |
Revenues recognized from current period increases | (27,804) |
Other | 1,011 |
Ending balance, March 31, 2023 | $ 107,169 |
Revenue Recognition Narrative (Details) - USD ($) $ in Millions |
Mar. 31, 2023 |
Dec. 31, 2022 |
---|---|---|
Revenue Recognition and Deferred Revenue [Abstract] | ||
Contract with customer, asset, gross | $ 61.3 | $ 57.0 |
Contract with customer, liability | $ 168.5 | $ 133.0 |
Revenue Recognition Remaing Performance Obligation (Details) $ in Millions |
Mar. 31, 2023
USD ($)
|
---|---|
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, Remaining Performance Obligation, Amount | $ 1,700 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period | 12 months |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, Remaining Performance Obligation, Amount | $ 1,800 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period | 12 months |
DN#WK,W=QNTFQ,RR;U]1B!>@